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Abstract 
In undifferentiated ES cells, many Polycomb Repressive Complex 2 (PRC2) target 
genes carry not only repressive H3K27me3 but are also enriched for conventional 
indicators of active chromatin including methylated H3K4. This so-called bivalent 
domain structure is thought to silence key developmental regulators while keeping 
them poised for future activation (or repression). Consistent with this hypothesis, 
bivalent genes assemble RNAP II preferentially phosphorylated on Serine 5 residues 
(poised RNAP II) and are transcribed at low levels. Productive expression is, however, 
prevented by the action of PRC1. 
Here, I have focused on the pre-implantation stage of mouse development to 
evaluate whether bivalent or poised chromatin signatures are indeed specific attributes 
of emerging pluripotent cells and investigate how the fate of key developmental genes is 
specified while the first lineage decision event (extra-embryonic lineage formation) 
occurs. Using blastocyst-derived stem cells and chromatin immunoprecipitation (ChIP), 
I have shown that lineage-inappropriate genes retain bivalent histone marking in extra-
embryonic trophoblast stem (TS). However, and in contrast to ES cells, PRC1 (Ring1B) 
and poised RNAP II are not recruited to these loci in TS cells, indicating that gene 
priming is a unique hallmark of pluripotent cells in the early embryo.  
To investigate the intricate relationship between lineage identity and dynamic 
chromatin changes, I exploited the potential to convert ES cells into trophoblast-like 
stem (TSL) cells using a previously established artificial system dependent on 
doxycycline (Dox) induced repression of an Oct4 transgene. I demonstrated that 
Suv39h1-mediated H3K9me3 alongside DNA methylation is targeted to PRC2-bound 
bivalent, lineage-inappropriate genes upon trophectoderm lineage commitment. A 
change in chromatin conformation was observed upon differentiation of ES cells to TSL 
cells comparable to that seen in TS cells derived in the traditional manner from the 
trophectoderm (TE) of blastocyst stage embryos. Most importantly, I have begun to 
explore when epigenetic differences are specified, at the locus level, from 8-cell stage 
embryos onwards using newly designed Carrier ChIP technology. This data validated 
the occurrence of bivalent chromatin domains in vivo and further support the view that 
alternative strategies operate in the TE to silence key developmental regulators upon 
blastocyst lineage segregation. 
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Chapter 1 – Introduction 
 
 Strictly regulated gene expression is essential for mammalian development and 
survival; selective use of identical genomes facilitates the generation of biologically distinct 
cell types within a single organism. How such diverse gene expression patterns are 
established and maintained in a reproducible manner during the course of development is 
a fascinating question. Differential gene expression can be influenced by many different 
factors; in this study the impact of chromatin based mechanisms have been explored.   
1.1 Chromatin context and gene regulation 
 The genome of a eukaryotic cell is contained within the nucleus, where it is 
assembled into chromosomes. These units are comprised of both DNA and proteins, which 
together are described as chromatin (as shown diagrammatically in Figure 1.1A). During 
cell division (mitosis or meiosis), chromosomes can be seen using a light microscope this is 
due to the high degree of chromatin condensation that occurs through supercoiling of the 
DNA and protein-protein interactions. Although interphase chromosomes are largely more 
relaxed, the classic model being a 30nm fibre, the degree of chromatin condensation varies 
along the chromosome length (Woodcock and Dimitrov, 2001).  For example centromeres 
and telomeres rich in repetitive sequences stain intensely indicating higher density; sites 
such as these are denoted constitutive heterochromatin (Passarge, 1979). Facultative 
heterochromatin formation, unlike constitutive, tends to be developmentally regulated and 
is dependent on cell type or stage in the cell cycle (Woodcock and Dimitrov, 2001). The 
most common example of facultative heterochromatin is the second female X chromosome 
that acquires an inactive heterochromatic state in early embryogenesis, which is later 
reprogrammed during germ cell development (Heard, 2004). In contrast, euchromatin 
refers to gene rich sites that are often involved in active transcription (Gilbert et al., 2004).  
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Figure 1.1 Chromatin organisation and the nucleosome. 
(A) Genetic information in the nuclei of eukaryotic cells is assembled into chromosomes, in 
which the DNA double helix is wrapped around nucleosomes forming a ‘beads on a string’ 
structure that is subsequently folded into higher order chromatin. Histone proteins within 
the nucleosome exhibit long flexible amino terminal domains (tails) in which specific 
amino acids are targets for a number of covalent modifications, including acetylation, 
methylation, poly(ADP)-ribosylation, phosphorylation and ubiquitylation. The nucleosome 
are depicted as yellow cylinders. The DNA is represented by black lines and the histone 
tails are shown as thin grey wavy lines. Acetylation is represented by (Ac), 
phosphorylation by (P), ubiquitylation by (Ub) and methylation is represented by (M). 
Adapted from (Sparmann and van Lohuizen, 2006). (B) High-resolution structure of the 
nucleosome core particle in which the DNA double helix is shown in blue and the histone 
H3 dimer in red, H4 in green, H2A in aqua and H2B in purple. Dynamic changes in 
chromatin structure are associated with post-transcriptional modifications of the N-
terminal tails of histones, which extend from the nucleosome core. Adapted from 
(Marmorstein, 2001). 
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 Although interphase chromosomes are largely more relaxed, they are not 
distributed at random but instead fill distinct territories within the nucleus (Branco and 
Pombo, 2006).  This 3D topography is fundamental to gene regulation as changes in 
chromosome configuration occur prior to transcriptional induction or repression 
indicative of a causal relationship (Palstra et al., 2003). Chromosome looping is known to 
facilitate genomic interactions between distal regulatory elements such as enhancers and 
target genes. In addition differences in chromosome arrangement have been noted upon 
cell differentiation and may therefore facilitate the generation of distinct gene expression 
repertoire. Together these studies illustrate the importance of considering genome 
function in its native context, the three-dimensional architecture of the cell nucleus. 
1.1.1 Nucleosomes 
 During interphase of the cell cycle chromatin can only be seen using an electron 
microscope, after gentle nuclear lysis a classic 30 nm fibre is visible while further 
treatment induces partial unfolding revealing structures that resemble ‘beads on a string’ 
(Davies and Small, 1968). The ‘bead’ structures observed by cytological analysis are the 
basic unit of chromatin - nucleosomes (Finch et al., 1977). The core nucleosome is 
comprised of histones (as illustrated in Figure 1.0.1B), small basic proteins with globular 
bodies and flexible N-terminal tails, which protrude through the coiled DNA at 
approximately every 20bp (Hansen et al., 1998).  Eight histone proteins, two of each, H2A, 
H2B, H3 and H4 form dimers and tetramers (H2A-H2B and H3-H4) before combining to 
comprise a compact octamer around which DNA is wrapped by 1.65 turns (147bp) in a 
left-handed coil (Luger et al., 1997). The stretch of nucleotides must undergo compression 
of the minor grove and equal expansion on the outer side. This observation led to the 
proposal that nucleosome positioning is non-random as structural restraints favour AT 
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base pairs on the inner positions and GC the outer. The point at which DNA enters and exits 
the nucleosome is occupied by linker histones such as the H1 class. Both DNA sequence 
and linker histone occupancy are thought to influence nucleosome periodicity, which can 
range from 10-80bp (Meersseman et al., 1992). ATP dependent chromatin remodeling 
complexes (SWI/SNF and ISWI family members) can alter the positions of the nucleosomes 
by disassembly of the nucleosome or sliding the octamer along DNA with minimal 
disruption of nucleosome structure often in association with gene transcription (Fazzio 
and Tsukiyama, 2003; Kornberg and Lorch, 1999; Travers, 1999).  The association 
between linker histones and nucleosomal DNA is much less stable than that of the 
nucleosome core particle interaction, which has an energetically favourable composition 
and is able to self-assemble under appropriate conditions. Incorporation of core histone H4 
(which has no variants) into nucleosomes only occurs in a replication dependent manner 
during S phase. In contrast, H3 variants (which differ between them by only a few amino 
acid residues) can be deposited in a replication and cell cycle phase-independent manner 
(Ahmad and Henikoff, 2002).  
 The H3 barcode hypothesis proposes that each H3 variant demarcates distinct 
chromatin states. Constitutive heterochromatin associates with H3.1, while facultative 
heterochromatin, is mostly occupied by H3.2 and euchromatin in which active gene 
transcription commonly occurs is  H3.3 rich (Hake and Allis, 2006).  This hypothesis stems 
from the observation that Saccharomyces Cerevisiae only contains the H3.3 variant and 
shows remarkably little evidence of conventional heterochromatin marks. While in 
contrast, Saccharomyces Pombe that contains a hybrid of H3.3 and H3.2 harbours 
heterochromatin more typical of higher eukaryotes. The roles of other histone variants are 
less clear, H2A.Z is an euchromatic variant associated with gene repression in yeast 
(Meneghini et al., 2003; Raisner et al., 2005; Santisteban et al., 2000) but it is localised to 
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heterochromatin in mammals (Fan et al., 2004). Other H2A variants also associate with 
silent chromatin for example Macro H2A is enriched on the inactive female X chromosome, 
the globular C-terminal and the histone-fold of Macro H2A are proposed to inhibit 
transcription factor binding and chromatin remodeling (Changolkar and Pehrson, 2006; 
Nusinow et al., 2007). While H2A-Bbd results in significantly less stable nucleosomes 
suggesting a role in transcriptional activation (Bao et al., 2004).  
 Although the H3 barcode hypothesis is an attractive one, it is predated by the more 
widely recognised histone code hypothesis (Jenuwein and Allis, 2001). This model draws 
attention to post-translational modifications on the highly conserved N-terminal histone 
tails, which protrude out from the globular nucleosome through the surrounding coiled 
DNA. Residues within these highly accessible domains are subject to a diverse range of 
modifications including acetylation, methylation, phosphorylation, ubiquitination, 
sumoylation and ADP-ribosylation. Such modifications were proposed to function in a 
interdependent manner as binding sites, facilitating the recruitment of specific proteins 
involved in gene regulation (Jenuwein and Allis, 2001). 
1.1.2 Histone acetylation 
 The cycle of lysine acetylation mediated by the transfer of acetate groups from 
acetyl-CoA by histone acetyltransferases (HATs) and subsequent removal by deacetylases 
(HDACs) is a highly dynamic process. The half-life of this post-translational modification 
can vary from a few minutes to several hours (Spotswood and Turner, 2002). There are a 
number of HATs and HDACs families - members of which largely reside in multimeric 
complexes. Gcn5 was first identified as a transcriptional co-activator in yeast more than 20 
years ago and has since been characterised as a HAT (Skvirsky et al., 1986). Other 
transcriptional co-activators such as p300/CBP, TAF130/250, P/CAF (a mammalian factor 
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similar to Gcn5) have all been shown to have HAT activity (Peterson and Laniel, 2004). In 
contrast, HDACs, associate with DNA condensation and silencing through recruitment of   
other factors such as Sin3a and interacting nuclear co-repressors, inducing gene repression 
at targeted sites within the genome. 
 Acetylation of lysine residues on histone tails neutralises their positive charge 
decreasing their affinity for the DNA. It has been proposed that this charge-mediated 
mechanism destablises folding of the chromatin fibre, permitting transcription factor 
access and facilitating gene expression (Hong et al., 1993). Transcriptionally active 
chromatin regions have been associated with acetylated histones for many years (Jeppesen 
and Turner, 1993; Pogo et al., 1966) a relationship that has since been confirmed by a 
number of genome-wide studies (Birney et al., 2007; Koch et al., 2007). 
1.1.3 Histone methylation 
 Lysine and arginine residues within H3 and H4 N-terminal tails are targeted by 
over 20 different histone methyltransferases (HMTs) in mammalian cells. Unlike 
acetylation, methylation is associated with both euchromatin and heterochromatin 
depending on the site and extent of modification. Tri-methylation of histone H3 lysine 4 
(H3K4), histone H3 lysine 36 (H3K36) and histone H3 lysine 79 (H3K79) are broadly 
associated with transcriptional activation and elongation (Guenther et al., 2007). In 
contrast, H3 lysine 9 (H3K9), H4 lysine 20 (H4K20), H3 lysine 27 (H3K27) and H3 lysine 64 
(H3K64) methylation correlate with silent transcriptional states (Daujat et al., 2009; 
Hublitz et al., 2009). 
 In mammals, Mixed lineage leukemia (MLL) proteins, Ash1L, Set7/9, Smyd1, 
Smyd3, and Prdm9/Meisetz are all capable of H3K4 methylation (See Figure 1.2) (Milne et 
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al., 2002).  MLLs and Set1 family members depend on other proteins such as Ash2L, RbBP5 
and WDR5 proteins for stable association with target residues, while Ash1 is dependent on 
non-coding RNA for targeting (Dou et al., 2006; Ruthenburg et al., 2007a; Wysocka et al., 
2005). Genome-wide studies in mammalian cells have recently shown that H3K4 tri-
methylation (H3K4me3) often forms a peak just downstream of the Transcriptional Start 
Site (TSS) and serves as a docking site to recruit additional chromatin remodeling 
complexes involved in transcriptional activity (Barski et al., 2007; Flanagan et al., 2005; 
Pray-Grant et al., 2005; Sims et al., 2005). H3K4 di-methylation (H3K4me2) is enriched 
more broadly across the TSS, the degree of enrichment for both H3K4me2/3 correlate with 
levels of expression (Guenther et al., 2007). The 3’-regions of transcribed loci associate 
with H3K36me3, a hallmark of elongation catalysed by Set2 (Bannister et al., 2005). 
H3K79me3 localises more closely to the TSS of active genes exceptionally this site lies 
within the globular domain of H3 and is methylated by Dot1L, which unlike all other 
known HMTs, does not contain a (Supressor of variegation-Enhancer of zeste-Trithorax) 
SET domain (Vakoc et al., 2006). 
 The SET domain was first identified in Suppressors of variegation (Suvar) proteins, 
which were discovered during a screen for genes involved in heterochromatin formation in 
Drosophila Melanogaster. Mammalian homologs - Suv39h1 and Suv39h2 were the first of 
many KMTs to be characterised in the mouse and were shown to catalyse tri-methylation 
of H3K9, creating a high-affinity binding site for the chromodomain of heterochromatin 
protein 1 (HP1) that, in turn, can recruit additional proteins to maintain and propagate a 
heterochromatic state (Hiragami and Festenstein, 2005; Ivanova et al., 1998; Lachner et al., 
2001). While, Suv39h1 predominantly localises to constitutive heterochromatin, Suv39h1 
and HP1 have also been implicated in gene silencing within euchromatic regions (Ait-Si-Ali 
et al., 2004; Nielsen et al., 2001). As shown in Figure 1.2 H3K9 (like H3K4) can be catalysed 
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by a number of different HMTs, preferentially regulating euchromatic sites within the 
genome these include; ESET, G9a, GLP and potentially SETDB2. The structurally distinct 
methyltransferase G9a catalyses H3K9 mono- and or di-methylation (Tachibana et al., 
2002), which can also serve as a substrate for HP1 binding, although with lower affinity 
(Jacobs and Khorasanizadeh, 2002). H3K9 KMTs such as GLP and ESET have also been 
shown to prevent gene activation through interaction with un-liganded nuclear receptors 
such as estrogen receptor (ERα) and catalyse repressive H3K9me2 at target promoters 
(Garcia-Bassets et al., 2007). 
 H3K27me3 mediated by Polycomb repressive complex (PRC) 2 is also associated 
with gene silencing. Embryonic ectoderm development (Eed) and Suppressor of zeste-12 
(Suz12) subunits act to recruit histone binding proteins RbAp46/ RbAp48 and stablise the 
complex (Cao et al., 2002; Czermin et al., 2002; Kuzmichev et al., 2002; Muller et al., 2002), 
while catalytic activity is conferred by HMTs denoted as Enhancer of Zeste (EZH).  
Canonical pathways induce H3K27me2/3 via Ezh2; Ezh1 is also capable of catalyzing the 
reaction, although to a lesser extent (Margueron et al., 2008; Shen et al., 2008). H3K27me3 
can mediate recruitment of further chromatin remodeling complexes such as Polycomb 
repressive complex 1 (PRC1). However, targeting of PRC1 to pericentric heterochromatin 
in early embryos or to the inactivated X during ES differentiation does not require 
H3K27me3, indicating that multiple mechanisms may contribute to targeting of this 
complex (Puschendorf et al., 2008; Simon and Kingston, 2009).  
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Figure 1.2. Summary of histone lysine methylation states and corresponding 
catalytic proteins. (A) H3K4 (orange) is widely correlated with a chromatin state that is 
permissive to transcriptional activity. H3K36 (green) is tightly associated with 
transcriptional elongation. (B) Repressed regions associate with H3K9 methylation (red) a 
site targeted by a number of enzymes. H3K27 methylation (purple) is the hallmark of 
Polycomb protein occupancy and gene silencing. Reciprocal demethylases of both H3K9 
and H3K27 act as co-activators. (C) As yet only K20 of H4 (blue) subject to methylation and 
is found at sites of constitutive heterochromatin. (D) Dot1L is the only known KMT without 
a SET domain and is uniquely targeted within the globular domain. H3K79 methylation 
(brown) is closely associated with active transcription. As yet no demethylase has been 
identified. KMTs are displayed above the histone tails and KDM below. Asterisks mark 
enzymes with multiple target sites. Image from (Hublitz et al., 2009) 
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1.1.4 Histone demethylation 
 Histone methylation was, until very recently, considered to be a stable post-
translational modification, which facilitates the inheritance of silent/active chromatin 
states through cell division. However, a number of histone demethylase (HDM) have since 
been discovered, the first of which lysine specific demethylase 1 (LSD1) is a member of the 
flavine oxidase family. LSD1 and has been shown to remove mono and di-methyl groups 
from H3K4 (Lan et al., 2007; Metzger et al., 2005). Evidence suggests however, that LSD1 
specificity and activity can be modulated through its interactions with other proteins, for 
example association with androgen nuclear receptor confers H3K9 demethylase activity, in 
this case resulting in transcriptional activation (Wissmann et al., 2007). However, 
consistent with a repressive function, LSD1 mediates H3K4 demethylation when 
associated with co-REST/HDAC complexes. (Metzger et al., 2005; Shi et al., 2004).  
 Other more recently identified demethylases belong to a family characterised by 
JumonjiC (JmjC) domains. This large protein family can be split into subgroups based on 
the sequence alignment of the JmjC domains and naturally cluster into groups with similar 
target residues (Cloos et al., 2008). For example members of the Jmjd2 subfamily are 
capable of demethylating H3K9me3/2 and H3K36me2/3 marks. Over-expression of 
Jmjd2a-c induces an overall decrease in H3K9me3/2 levels and delocalisation of HP1, 
indicating an antagonistic effect on heterochromatin (Shin and Janknecht, 2007). The 
Jarid1 subfamily consists of four members (a-d), which all target H3K4me3/2 and 
consequently function as co-repressors, best illustrated by Jarid1a recruitment to silent 
Hox genes (Christensen et al., 2007). Thirdly, the Utx/Jmjd3 cluster target H3K27me3/2 
and have, in contrast, been associated with K4 KMTs and Hox gene activation. 
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1.1.5 Histone ubiquitination 
 H2A and H2B are subject to ubiquitination at lysine 119 and 120 respectively 
(Moore et al., 2002). Unlike any of the previously described modifications the addition of 
ubiquitin to H2A increases its size by approximately 8 KDa (Wang et al., 2004). The 
targeted residues are also less accessible, suggesting that this post-translational 
modification may not act as a binding site to recruit further complexes but directly 
interfere with chromatin remodeling activity. Intriguingly however, H2B ubiquitination has 
a positive effect on transcription while, in contrast, H2A ubiquitination mediated by PRC1 
member Ring1A/B and is correlated with gene silencing (de Napoles et al., 2004). The 
mechanisms underlying these differential effects are yet to be understood.  
 The core subunits of PRC1 include Ring1A/B, posterior sex combs (Bmi-1 and Mel-
18), Polycomb (Cbx2, Cbx4 and Cbx8) and polyhomeotic (Phc1, Phc2, and Phc3) proteins. 
Ring1A/B act as ubiquitin ligases, which when complexed with Bmi-1 or phosphorylated 
Mel-18 specifically catalyse the ubiquitination of lysine 119 of H2A (de Napoles et al., 2004; 
Elderkin et al., 2007).  Crosstalk between histone modifications is probably best illustrated 
by the association of PRC1 with H3K27me3 through Cbx proteins, which show binding 
affinity for both the modified histones and Ring1A/B in vitro (Bernstein et al., 2006b; 
Garcia et al., 1999; Whitcomb et al., 2007). Methylation of H3K9, H3K27 and ubiquitination 
of H2A are all associated with the inactive female X chromosome, where silencing is 
initially induced by coating with non-coding RNA Xist (Senner and Brockdorff, 2009). 
Interestingly, Zhu and colleagues have recently described a deubiquitinating enzyme that 
specifically targets monoubiquitinated H2A upon recruitment by nuclear receptors; 
authors propose that additional H2A ubiquitin ligases/deubiquitinases are likely to be 
identified in the coming years (Zhu et al., 2007).  
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1.1.6 Other post-translational modifications of histone tails  
 Residues other than lysine in the histone tail are also subject to post-translational 
modification. For example, arginine methylation is a relatively abundant modification, 
however, data on its functions are limited (Boisvert et al., 2005).  Arginine-specific protein 
methyltransferase (PRMT) - CARM1 is recruited by nuclear receptors and catalyses R17 
and R26 methylation at transcriptionally induced loci (Bauer et al., 2002). Demethylation 
of arginine residues can occur via deimination and conversion to citrulline by members of 
the peptidyl arginine deiminase (PADI) family (Cuthbert et al., 2004). However, a member 
of the recently identified family of demethylases - Jmjd6 has since been proven to show 
specificity for H3R2me2 and H4R3me2 (Chang et al., 2007). It is expected that Jmjd6 
functions as co-activator, due to an antagonistic relationship between H3R2 (asymmetric) 
and H3K4me3 (Guccione et al., 2007).   
 Other types of histone modification include sumoylation, ADP-ribosylation and 
phosphorylation and it is likely that more await description. H3 Serine 10 is a well- 
characterised example of one such modification that is mediated by Aurora B kinase, 
widely considered as a cell-cycle regulated kinase often detected in association with 
H3K9me3 (H3K9me3/S10ph) on mitotic chromosomes (Hendzel et al., 1997; Van Hooser 
et al., 1998; Wei et al., 1998). More recently, however, it has become clear that S10 
phosphorylation also plays a role in gene silencing during differentiation (Sabbattini et al., 
2007). H3 theronine 3 and S28 are also subject to phosphorylation, however, the function 
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 In summary, the various post-translational modifications of the histone tail have 
been shown to annotate the transcriptional state of a locus, while often providing docking 
sites for appropriate catalytic complexes (Jenuwein and Allis, 2001). Several proteins 
domains have been indentified that recognise and interact with methylated lysines 
including chromo, tudor and WD40-repeat domains (Martin and Zhang, 2005). Those that 
associate with methylated H3K4 are involved in transcriptional activity (Pray-Grant et al., 
2005; Wysocka et al., 2005), while those that bind methylated H3K9 or H3K27 have been 
consistently implicated transcriptional repression (Fischle et al., 2003; Min et al., 2003). It 
is clear that the histone code is a complex one in which acetylation, methylation, 
ubiquitination and phosphorylation, amongst others, are not added or interpreted in 
isolation but that consistent cross talk occurs between modified residues: on the same tail, 
within dimers, between tetramers and likely between nucleosome (Ruthenburg et al., 
2007b). Our understanding of the histone code has evolved into a complex language with 
seemingly delicate nuances between diverse cell types (Berger, 2007).  
1.1.7 DNA methylation 
 The DNA of vertebrate animals can be covalently modified by methylation of the 
cytosine base of CpG dinucleotide dimers, CpG is an abbreviation for cytosine and guanine 
separated by a phosphate, which links the two nucleotides together in DNA. In mammals, 
DNA methyltransferase enzymes Dnmt3A and Dnmt3B have traditionally been considered 
as de novo methyltransferases responsible for establishing methylation patterns during 
embryonic development. While Dnmt1 ensures the stable inheritance of  DNA methylation 
through cell division through a copying mechanism, which targets hemi-methylated DNA 
(Pradhan et al., 1999). The heritability of DNA methylation is thought to confer a means of 
cell memory as initially proposed by (Holliday and Pugh, 1975; Riggs, 1975).  
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 The mechanism by which de novo methyltransferases are targeted in different cell 
types is, however, less well understood. Some studies suggest Dnmts are recruited in a 
sequence specific manner while others favour positive crosstalk between histone tail 
modifying complexes or non-coding RNA recruitment (Fuks et al., 2003b; Lehnertz et al., 
2003; Turker, 1999; Vire et al., 2006).  
 Although DNA methylation is capable of directly impeding transcription factor 
binding, methylation of naked DNA in vitro had little effect on transcription rates. It   
Disruption of transcription in vivo is therefore more likely mediated through recruitment 
of proteins, which preferentially bind methylated DNA such as methyl-CpG binding 
proteins (MBD). MBDs interact to form a complex denoted MeCP1/2 and associate with 
HDACs to repress transcription (Boyes and Bird, 1991; Holmgren et al., 2001). MeCP1 
binding  is dependent on the degree of methylation, consequently gene silencing is 
determined not by the presence or absence of methylation but on its density, active genes 
can therefore tolerate low levels of methylation (Weber and Schubeler, 2007). 
 DNA methylation is commonly associated with long-term silencing of large 
fractions of the genome including repetitive elements such as transposons and satellite 
DNA, pericentric heterochromatin, the inactive X, and imprinted genes in which one allele 
is silenced depending on its parental origin. DNA methylation is often regarded as a 
mechanism used to consolidate chromatin states and thus described as a late event during 
the process of X-inactivation (Heard, 2004). Like histone methylation, DNA methylation 
was also largely considered as irreversible in somatic cells, consistent with a role in cell 
memory.  Recent studies, however, have proposed active demethylation of DNA can occur 
through a protein called Gadd45, which works in concert with nucleotide excision repair 
enzymes (Barreto et al., 2007).   
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1.2 Early mouse development 
1.2.1 Paternal and maternal genome reprogramming 
 Upon fertilisation genomes of the male and female gametes are thrust into the 
same arena to form the zygote. Sperm-oocyte fusion induces completion of meiosis II in the 
egg, which expels a second polar body. The paternal genome, which has been densely 
packed around basic protamines and sperm-specific histone variants, decondenses using 
the gluthione in the egg cytoplasm to reduce disulfide bonds and rapidly acquires H3K9 
acetylation on maternally inherited histones (Calvin and Bedford, 1971; Kvist, 1980; 
Perreault et al., 1988). At this time the paternal genome also begins to undergo active 
genome-wide DNA demethylation with the exception of imprinted genes, which like the 
maternal genome are protected from this process (Reik and Dean, 2001). A passive 
reduction of DNA methylation is also observed with each nuclear division, probably due to 
nuclear depletion of Dnmt1 ensuring a more uniform distribution of this epigenetic mark 
before blastocyst formation (Carlson et al., 1992). Prior to DNA replication the maternal 
chromosomes stain intensely for DNA methylation and Suv39h1 mediated K9 methylation 
and H3K27me3 at pericentric and centric heterochromatin. In contrast, the pericentric 
heterochromatin of the paternal genome is depleted of these repressive histone 
modifications and is instead bound by the PRC1 component Ring1B (Puschendorf et al., 
2008; Santos et al., 2005). Epigenetic asymmetries between parental genomes have been 
shown to persist at constitutive heterochromatin until the 8-cell stage.  How such non-
equivalence is tolerated and maintained through cell division is not yet understood.  
 Interestingly a subset of genes retain parent of origin marks in somatic cells 
throughout development and are referred to as imprinted loci. Differential DNA 
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methylation, histone phosphorylation, acetylation and methylation and corresponding 
binding proteins at maternal and paternal alleles give rise to monoallelic expression 
patterns in a tissue and developmental stage dependent manner often affecting genes 
involved in regulating embryonic and neonatal growth (Meehan, 2003). For example 
Insulin growth factor 2 expression occurs exclusively from the paternally-inherited allele 
and its receptor Ifg2R from the maternally-inherited allele. (Lyle, 1997).  
 
1.2.2 Embryonic versus extra-embryonic cell fate decisions 
 Mammalian embryos are amongst the slowest to divide and do so in a unique 
fashion. The first cleavage is a normal meridional division; while during the second 
cleavage, one of the two blastomeres usually divides meridionally and the other 
equatorially (rotational cleavage) (Gulyas, 1975).  After the 8-cell stage, cells begin a 
process of compaction, maximising their contact with one another and forming a 
compressed ball stabilised by tight junctions between outer cells. Smaller, inner cells in 
contrast, form gap junctions allowing diffusion of small molecules and ions. Cells of the 
compacted 8-cell embryo divide to produce a 16-cell morula in which descendants of 
larger outer cells show a greater tendency to commit to the trophoblast lineage. The 
morula undergoes cavitation as the activity of sodium pumps (Na+, K+-ATPases) in outer  
cells create ionic gradients causing the accumulation of fluid in the morula, thus creating a 
blastocoel cavity (Watson et al., 1992). Further blastocoel expansion occurs in response to 
aquaporin dependent water movement across the TE (Barcroft et al., 2003). A group of 
cells denoted the inner cell mass (ICM) become positioned on one side of the surrounding 
sphere of trophoblast cells forming the mammalian blastocyst (as shown in Figure 1.3). At 
the late blastocyst stage when the blastcoel has fully expanded, a second lineage 
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segregation event occurs marked by the emergence of primitive endoderm (PrE) from the 
ICM. Together extra-embryonic lineages facilitate maternal-fetal interactions and provide 
essential support to the developing inner cell mass (ICM) and epiblast (EPI) from which 
the embryo will form. In this study I will focus the first differentiation event in mammalian 






Figure 1.3. Schematic representation of the early stages of mouse development. Cells 
of the eight-cell embryo undergo compaction as development progresses to the compacted 
morula in which cell boundaries become difficult to distinguish. Subsequent divisions lead 
to the generation of distinct inner (green) and outer cells (orange). Subsequently an 
internal cavity, the blastocoele forms and two distinct lineages are apparent in the early 
blastocyst stage: the trophectoderm (TE) and the inner cell mass (ICM). Cells within the 
ICM start to express different levels of transcription factors such as Nanog (green) and 
Gata6 (blue) is a salt and pepper fashion. As the balstocyst fully expands, the ICM further 
segregates into two lineages: the epiblast (EPI) in green and the primitive endoderm (PrE) 
in blue. The polar trophectoderm cells (overlying the ICM) continue to proliferate giving 
rise to the diploid extra-embryonic ectoderm (EXE) and ectoplacental cone (EPC), mural 
trophectoderm (away from the ICM) stop dividing but continue to endoduplicate their DNA 
to form trophoblast giant cells and facilitate implantation. Embryo stages not drawn to 
scale. 





 The mechanisms underlying ICM versus TE cell fate acquisition have been a matter 
of some interest and debate for a number of years. Evidence of differentially distributed 
determinants in Drosophila and Xenopus oocytes led to the hypothesis that an early 
asymmetry (between animal and vegetal poles) is likely to exist in the mammalian egg.  
However, no such asymmetries have yet been identified in the mammalian ooctye. 
Whether early bias exists in blastomeres of the early embryo remains a controversial 
research topic. Most recently evidence of bias at the 4 cell-stage was uncovered; 
blastomeres that inherit both animal and vegetal components of the zygote were shown to 
have higher levels of H3R17 and H3R26 methylation than those inheriting only the vegetal 
components and have a greater tendency to contribute towards the ICM than the TE. Over-
expression of the enzyme responsible for the observed arginine methylation (Carm1) led 
cells to adopt an embryonic cell fate (Torres-Padilla et al., 2007). Epigenetic asymmetries 
have also been identified at the blastocyst stage with higher levels of DNA and H3K27 
methylation in the ICM compared to the TE (Erhardt et al., 2003; Mak et al., 2004; Santos et 
al., 2002).  Although bias may exist within blastomeres of the early embryo it is clear from 
cell repositioning experiments that bias does not equate to lineage restriction as changing 
the location of a cell within the early embryo induces a switch in lineage identity. This 
indicates that environmental differences between inner and outer positions may further 
influence cell identity by perhaps reinforcing early bias (Fleming and Johnson, 1988; 
Tarkowski and Wroblewska, 1967).  
 Data showing that cell polarity proteins localise differentially within blastomeres of 
the 8-cell embryo stage further supports the regulative inside-outside hypothesis. 
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Asymmetric division of polar cells leads to the differential inheritance of polarization 
properties, with the outer daughter cell retaining polarity while the inner cell becomes 
apolar. Artificial down-regulation of polarity associated proteins e.g. Par3 in outer cells led 
to cell fate switching, consistent with cell repositioning experiments (Ralston and Rossant, 
2008). The adaptive capacity of the mammalian embryo and the lack of suitable orientation 
markers, has somewhat hampered attempts to define a model to demonstrate how early 
cell fate decisions normally occur during development. However, evidence emerging from 
the use of new technologies is starting to suggest that a combination of the previously 
proposed theories is likely to occur during normal development (Zernicka-Goetz et al., 
2009).  
1.2.3 Transcription factors and lineage identity in the early embryo 
 Work over recent years has revealed that cell identity at the blastocyst stage is 
strongly influenced by transcription factors such as Oct4 and Cdx2. Oct4 is uniformly 
expressed in blastomeres of cleavage stage embryos and gradually becomes restricted to 
the pluripotent ICM. Its expression persists in the embryo proper until gastrulation where 
it becomes restricted to developing germ cells.  Oct4 null embryos are unable to maintain 
an ICM and cells instead divert towards the trophoblast lineage disrupting any further 
development (Nichols et al., 1998).  Oct4 is considered as a gatekeeper of pluripotency, 
repressing differentiation associated genes and stimulating the expression of factors 
associated with maintaining a developmentally naive state (Boiani and Scholer, 2005).  
 Unlike Oct4, the earliest time point at which the caudal-type homeodomain protein 
Cdx2 has been detected is the 8-cell stage. Intriguingly RNAi knockdown of Cdx2 at the 2 
cell stage leads to a stronger phenotype than a zygotic mutant, which has led some to 
propose that a maternal pool of Cdx2 mRNA may exist (Zernicka-Goetz et al., 2009). Initial 
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Cdx2 expression is thought to occur in a non uniform manner with the protein often 
appearing in only 2 of the 8-cells before progressively increasing throughout the embryo, 
(Dietrich and Hiiragi, 2007; Ralston and Rossant, 2008). Cdx2 like Oct4 can both activate 
and repress transcription, it enhances the expression of targets genes associated with 
trophoblast self renewal and reduces the transcriptional activity of ICM associated Oct4 
(Ogawa et al., 2005). Cdx2 null mice are unable to maintain blastocoel cavities, largely due 
to disrupted tight junctions and increased cell death; consequently blastocyst expansion is 
disrupted and implantation is unable to occur (Strumpf et al., 2005). 
1.2.4 Blastocyst-derived stem cells    
 The derivation of stem cells from the blastocyst stage embryo has greatly enhanced 
our understanding of the first lineage commitment event in mammalian development. 
Embryonic stem cells were first derived from the ICM of blastocysts in 1981, since this 
time numerous cell lines have been established from many different genetic backgrounds, 
which now function as fundamental tools in the study of developmental biology (Evans and 
Kaufman, 1981). Mouse embryonic stem (ES) cells are both self-renewing and pluripotent, 
meaning they can be maintained indefinitely in vitro and retain the potential to 
differentiate into all three germ layers of the embryo (Evans and Hunter, 2002). When 
introduced back into a blastocyst, ES cells contribute to all tissues of the developing 
embryo critically including the germline, while injection into an immunologically 
compromised adult mouse gives rise to teratocarcinomas, which contain diverse cell types 
characteristic of all three embryonic layers. 
 The derivation of trophoblast stem (TS) cells in 1998 is a more recent achievement 
(Tanaka et al., 1998). Although these cells receive more limited attention they too are able 
to indefinitely self-renew in culture and maintain their cognate developmental potential. In 
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the early embryo trophoblast cells form a layer, referred to as the trophectoderm (TE), 
which encapsulates the ICM creating the blastocyst. Trophoblast cells overlying the ICM 
are stimulated to proliferate by signals from the underlying ICM. Pluripotency-associated 
transcription factors Oct4 and Sox2 together enhance the expression of fibroblast growth 
factor 4 (Fgf4), which is essential for the expansion of the extra-embryonic ectoderm in 
vivo and the derivation and maintenance of TS cells in vitro (Tanaka et al., 1998), 
demonstrating the interdependence of each of the early lineages for survival, patterning, 
and differentiation (Rodriguez et al., 2005; Saitou et al., 2002; Tanaka et al., 1998). 
Withdrawal of Fgf4 and mouse embryonic fibroblasts (Mef) in vitro induces trophoblast 
stem cells to differentiate, predominantly forming trophoblast giant cells characterised by 
flatten cytoplasm, high ploidy commonly due to endoreduplication and dark perinuclear 
deposits, such cells are inherently invasive and phagocytic. In vivo the polar trophectoderm 
will initially form a flat plate called the chorion, which retains expression of markers 
associated with trophoblast self-renewal and will attach to the allantois and fold into 
primary villi. Two layers of multinucleated syncytiotrophoblast will arise from 
differentiated chorionic trophoblasts, creating the labyrinth, a barrier for maternal and 
fetal exchange (Natale et al., 2006).  
  Derivation of stem cells from the blastocyst have enabled elegant experiments to 
be conducted in vitro, pouring light on the biological significance of restricted transcription 
factor expression patterns in the early embryo.  ES cells in which one or both endogenous 
Oct4 alleles were disrupted and a tetracycline (Tc) regulated Oct4 transgene introduced 
have been generated and are denoted ZHBTc6 and ZHBTc4, respectively (Niwa et al., 
2000). Experiments using this cell system demonstrated that the level of Oct4 expression 
strongly influences cell identity. Over-expression of Oct4 in ZHBTc6 cells led to extra-
embryonic endoderm and mesoderm differentiation. While tetracycline induced 
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repression of Oct4 in ZHBTc4 cells led to extra-embryonic trophoblast differentiation. 
Remarkably, ICM-derived ES cells had never before been proven capable of differentiation 
towards a trophoblast cell fate. Furthermore such TS-like (TSL) epithelial cell colonies 
could be derived and propagated in appropriate supportive conditions by induced Oct4 
repression.   
 The relationship between transcription factors and cell identity in the early embryo 
was further explored by over-expression of TE-associated Cdx2 in ES cells. Inducible 
expression of a Cdx2 transgene in the ZHBTc4 ES cell system also led to the derivation of 
TS-like populations (Ogawa et al., 2005). Interestingly, this could be achieved even in the 
sustained presence of Oct4, demonstrating that an imbalance between the two 
transcription factors is sufficient to influence cell identity. Even though Oct4 expression 
was artificially maintained in these in vitro experiments, the expression levels of Oct4 
targets such as Fgf4 were diminished indicative of compromised function. A more direct 
inhibitory interaction between these two transcription factors was also suggested by 
evident co-localisation of Cdx2 and Oct4 at transcriptionally inactive regions, in addition 
Cdx2 binding sites were identified in close proximity to those of Oct4 at the auto-
regulatory region of the promoter (Ogawa et al., 2005).  
 Although Cdx2 is essential for maintaining TS cell populations, surprisingly, it is not 
necessary for acquisition of a TE cell fate.  Oct4 repression in cells with disrupted 
endogenous Cdx2 alleles was also sufficient to drive differentiation – illustrative of 
redundancy, most likely with TE-associated Eomes (Ogawa et al., 2005).  The auto-
regulative nature of both Oct4 and Cdx2, revealed in these studies, suggests that once a 
slight imbalance between Oct4 and Cdx2 proteins is created, mutual inhibition can amplify 
this asymmetry, resulting in a reciprocal expression pattern in the ICM and TE (Ogawa et 
al., 2005; Okumura-Nakanishi et al., 2005; Xu et al., 1999). An even more recent 
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investigation demonstrated that cell-cell contacts of the inner embryo diminish Cdx2 
expression by inhibiting upstream Tead4 activity. In contrast, Tead4 co-activator - Yap is 
able to localize to the nucleus in outer cells and induce Cdx2 expression (Nishioka et al., 
2009).   
1.3 Genetic and epigenetic regulation of pluripotency  
1.3.1 Core transcription factor network 
 The transcriptional networks controlling pluripotency have been the focus of 
intensive research, Oct4 is known to complex with homeodomain transcription factor 
Nanog and SRY-related HMG-box transcription factor Sox2 (Boyer et al., 2005). Mutation of 
any single factor results in loss of pluripotency in the early embryo (Mitsui et al., 2003; 
Nichols et al., 1998; Strumpf et al., 2005). Nanog expression is evident by the 8-cell stage 
and like Oct4 becomes restricted to the developing germ cells during gastrulation. Mouse 
ES cells deficient for Nanog are self-renewing, but show an increased propensity to 
differentiate and cannot give rise to mature germ cells when injected back in vivo, 
suggesting that Nanog is required for establishing, but is dispensable for maintaining the 
pluripotent state (Chambers et al., 2003; Chambers et al., 2007). Sox2 expression is not 
restricted in the same manner; however, it consistently associates with stem cell 
populations such as the uncommitted dividing precursor cells of the developing central 
nervous system (CNS) (Avilion et al., 2003).  Together Oct4, Nanog and Sox2 transcription 
factors have been proposed to control a core regulatory network associated with 
pluripotency. Genome-wide ChIP analysis showed that this complex targets a wide variety 
of genes including their own promoters (Boyer et al., 2006a; Loh et al., 2006). Binding of 
this core transcription factor complex was shown to enhance the expression levels of 
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numerous other transcription factors, chromatin remodeling factors and components of 
signaling pathways known to be important for ES cell biology. In contrast, repressed 
targets were found to encode differentiation-related genes associated with ectoderm, 
endoderm, mesoderm and extra-embryonic lineage specification(Loh et al., 2006). 
1.3.2 ES cell chromatin environment 
 The nuclei of pluripotent ES cells are approximately twice the volume of 
differentiated cells, indicative of a distinct nuclear environment (Faro-Trindade and Cook, 
2006). ES cells have been shown to have largely open and accessible genomes, 
demonstrated by the presence of acetylated histones and widely nuclease sensitive 
chromatin (Lee et al., 2004). In contrast, differentiation is associated with the accumulation 
of transcriptionally inactive heterochromatic regions (Boyer et al., 2006a). Using 
replication timing-based analysis, the chromatin signature of ES cells was compared to 
multipotent hematopoietic stem cells and fully differentiated T cells. Early replication is 
generally considered to be a feature of gene rich, expressed regions of the genome and 
correlates with accessible chromatin, carrying acetylated histones (Lin et al., 2003; Perry et 
al., 2004; Vogelauer et al., 2002). While in contrast, late replication is associated with 
constitutive heterochromatin and some facultative heterochromatin, formed through gene 
repression (Gilbert, 2002). Many non-expressed genes were found to replicate early in ES 
cells, reflecting a uniquely open and accessible genome, while more committed cells had a 
higher proportion of late-replicating loci. For example, although neural-specifying loci are 
not expressed in either cell type, they replicate early in ES cells (that retain neural 
potential) and later in hematopoietic-restricted cells (that lack neural potential) (Azuara et 
al., 2006). 
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 Interestingly, the permissive chromatin environment of ES cells was also 
demonstrated using FRAP to measure exchange rates of HP1 and linker histone H1. The 
mobility of these chromatin-associated proteins was found to be higher in ES cells, 
suggesting developmental plasticity is conferred by a more dynamic milieu (Meshorer et 
al., 2006).  This finding has been further confirmed by research on a chromodomain 
protein called Chd1, a chromatin-remodeling enzyme that recognises H3K4me2/3. 
Depletion of Chd1 in ES cells compromises the rapid exchange of H1 and cells show a more 
restricted developmental potential with preferential differentiation towards neurogenesis. 
In addition unlike wild-type fibroblasts, it is not possible to reprogram Chd1 -/- fibroblasts 
through forced expression of reprogramming-associated transcription factors Oct4, Sox2, 
Myc and Klf4. Interestingly, stem cell related genes were reactivated as expected during 
this process while repression of lineage specific transcription factors was inadequate, 
disrupting the restoration of pluripotency (Gaspar-Maia et al., 2009). This study highlights 
the requirement for core transcriptional machinery and chromatin-modifying complexes 
to work in concert to achieve a pluripotent state. 
1.3.3 Poised chromatin signatures at key developmental regulators in ES 
cells  
 In 2006, two independent studies - the first analysing Oct4, Nanog and Sox2 bound 
loci and the second analysing PcG occupied genes - revealed an intriguing number of 
common targets (Boyer et al., 2005; Boyer et al., 2006b; Loh et al., 2006). Concomitantly, 
many of these loci were shown to be marked by both PcG-mediated H3K27me3 and 
trithorax-mediated H3K4 methylation, which were historically considered as mutually 
exclusive (Azuara et al., 2006; Bernstein et al., 2006a). Targets genes were shown to 
commonly encode transcriptional regulators such as Sox, Fox, Pax, Irx and Pou domain 
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containing factors, often implicated in developmental patterning - segmentation, eye and 
limb development. The co-occupancy of both H3K4 and H3K27 methylation forms a 
bivalent chromatin domain at the 5’ region of loci; such a signature has been proposed to 
prime a gene for expression later in development while preventing premature 
transcription (Azuara et al., 2006; Bernstein et al., 2006a). This hypothesis was supported 
by the fact that   ES cells lacking H3K27 tri-methylation due to genetic disruption of the 
PRC2 components Eed or Suz12, showed inappropriate expression of genes associated with 
differentiation (Azuara et al., 2006; Boyer et al., 2006b; Lee et al., 2006). It is also 
noteworthy that Eed-deficient cells are prone to spontaneous differentiation, further 
highlighting a link between PRC2, gene silencing and pluripotency. 
 Subsequent analysis of bivalent chromatin domains using genome-wide 
technologies comparing H3K4me3 and H3K27me3 patterns in ES cells, Mef and Neural 
precursors cells (NPC) led to an unequivocal association of bivalent domains with high CpG 
containing promoters (HCP) indicating that CpG poor promoters are subject to distinct 
modes of regulation (Mikkelsen et al., 2007). Over 2000 promoters were found to be 
occupied by both H3K27me3 and H3K4me3 in pluripotent ES cells, while approximately 
1100 and 200 were identified in Mefs and NPC, respectively (Mikkelsen et al., 2007). The 
reduced prevalence of bivalent chromatin domains in developmentally restricted cell types 
compared to pluripotent ES cells was consistent with the hypothesis that such structures 
function to poise loci for potential activation or repression upon differentiation. As shown 
diagrammatically in Figure 1.4, ES cell differentiation induces previously poised loci to 
resolve to either H3K4me3 or H3K27me3 consistent with transcriptional status or lose 
both histone modifications. Primary T cells were also shown to harbor a number of 
bivalent chromatin domains at loci associated with the immune response, this finding is 
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consistent with the idea that bivalent chromatin maintains genes is a poised state enabling 





Figure 1.4. Schematic representation of bivalent chromatin domain resolution upon 
lineage commitment. H3K27me3 and H3K4me2 co-occupy many loci associated with the 
regulation of key developmental pathways in ES cells, forming bivalent chromatin 
domains. Such structures have been reported to largely resolve upon ES cell differentiation 
to either H3K4me2 only, H3K27me3 only or are no longer marked by either histone 
modification, in accordance with transcriptional status. In this schematic H3K27me3 and 
H3K4me2 are depicted on different nucleosomes to reflect the broad domains of 
H3K27me3 and the peaks of H3K4me2 observed by ChIP-seq experiments , however these 
two modifications may occur on the same histone tail or within in the same octamer, this 
remains to be determined.  
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 Genome-wide analysis of bivalent chromatin domains in ES cells demonstrated that 
40% were co-occupied by PRC1 and PRC2 while the remaining 60% were targeted by 
PRC2 alone. Promoters bound by PRC2 alone largely encode membrane proteins or genes 
of unknown function and show a greater tendency to lose H3K27me3 upon differentiation 
(10% are maintained). In contrast, PRC1 occupied loci were evolutionarily conserved and 
found in clusters of key developmental transcription factors within large H3K27me3 
domains (Ku et al., 2008). Experiments using inducible Ring1A/B knockout cells 
demonstrated that 32% of PRC1 positive bivalent loci are up regulated after 48 hours 
treatment, compared to 16% of those occupied by PRC2 alone (Ku et al., 2008).   
 Aberrant expression of loci usually occupied by PRC1 is consistent with the finding 
that an unusual conformation of RNAP II also occupies such promoters in ES cells (Stock et 
al., 2007). During a conventional transcription cycle a large multi-subunit complex – the 
mediator acts a bridge between upstream activator proteins, RNAP II and the general 
transcription factors. The pre-initiation complex (PIC) is formed by TFIID that recognises 
promoters and is stabilised by TFIIB during recruitment of RNAP II and the other general 
transcription factors. Intrinsic helicase activity melts the DNA at promoters allowing access 
to a single stranded template and formation of the first phosphodiester bond. RNAP II 
contains a C-terminal domain (CTD) heptad consensus repeat sequence Tyr1-Ser2-Pro3-
Thr4-Ser5-Pro6-Ser7, which is subject to complex phosphorylation patterns (Buratowski, 
2003; Maniatis and Reed, 2002; Saunders et al., 2006). Phosphorylation of the RNAP II on 
Ser5 residues by CDK9 induces release from mediator interaction at the promoter (Lu et 
al., 1992; Max et al., 2007).  Further phosphorylation by CDK7 on Ser2 CTD residues 
corresponds to the formation of a stable elongation complex (Dahmus, 1996).  Termination 
of transcription is likely coupled with mRNA cleavage and polyadenylation, while RNAP II 
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is subject dephosphorylation and recycled (Krishnamurthy et al., 2004; Mandal et al., 
2002). 
 In ES cells, an unusual conformation of RNAP II highly phosphorylated at the Ser5 
but not Ser2 and not reactive with an antibody raised against the hypophosphorylated 
form (8WG16) occupies PRC1 positive loci.  Inducible depletion of Ring1A/B, the catalytic 
components of PRC1 led to; reduction in H2A ubiquitination levels, increased transcript 
levels and detection of RNAP II by the 8WG16 antibody (Stock et al., 2007).  Promoters of 
readily inducible genes such as those encoding heat shock proteins (e.g. hsp26) also recruit 
RNAP II even in the un-induced state and are often co-occupied by PcG proteins known to 
influence downstream events in the transcription cycle (Dellino et al., 2004; Zhou et al., 
2008). However, paused RNAP II observed at promoters such as hsp26 can be detected by 
8WG16 and does not extend into the coding region. The conformation of RNAP II observed 
at bivalent domains in ES cells has instead been described as a poised RNAP II (Stock et al., 
2007). Authors propose that the poised conformation of RNAP II is also distinct from PIC 
assembly at early transcription competence marks (ETCMs) previously observed at 
lineage-specific inactive genes in ES cells in which RNAP II is modulated by 26S 
proteasome (Szutorisz et al., 2005; Szutorisz et al., 2006). Together these studies show that 
the chromatin architecture of ES cells functions to maintain tissue-specific gene loci in a 
primed state ready for rapid gene expression changes and accompanying differentiation. 
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1.4 Aims of Study 
 Early replication, enhanced chromatin accessibility and bivalent or poised 
chromatin signatures at the promoters of key developmental genes in ES cells are new and 
surprising discoveries that may influence how pluripotency and lineage flexibility are 
perceived. An important challenge is to establish whether the epigenetic features of ES 
cells are also seen in the developing embryo and how (and when) bivalent chromatin 
signatures are established and subsequently erased or modulated upon lineage 
commitment. In this study I will focus on mammalian pre-implantation development – a 
unique model for studying pluripotency and key development decisions. Using mouse 
embryo-derived stem cells I aim to advance understanding of how pluripotency is 
maintained in the ICM while surrounding cells undergo TE lineage restriction. In addition, 
the status of a selection of candidate genes will also be examined in vivo. This work will be 
presented along three main veins. Firstly, I will address whether bivalent or poised 
signatures uniquely mark the pluripotent (embryonic) compartment in the early mouse 
embryo by comparing the epigenetic profiles of ES and TS cells. Secondly I will determine 
whether additional repressive mechanisms operate in TS cells to silence embryonic-
associated genes and explore the process of chromatin remodeling upon TE cell fate 
acquisition using an in vitro ES cell differentiation system. Finally I will examine in vivo 
how and when epigenetic differences are specified, at the locus level, between embryonic 
and extra-embryonic lineages. 
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Chapter 2 - Material and methods  
 
2.1 Cell lines and cell culture  
TS-B1 cells (Mak et al., 2002) were a kind gift from Neil Brockdorff,  Developmental 
Epigenetics Group, University of Oxford. TS cells were cultured either on mitotically 
inactivated mouse embryonic fibroblast (Mef) or in the presence of 30% RPMI 1640 
medium and 70% media conditioned by supplemented with 20% FCS, sodium pyruvate 
(1mM), 2-mercaptoethanol (0.1mM), L-glutamine (292µg/ml), penicillin/streptomycin 
(100U/ml) and human recombinant fibroblast growth factor (Fgf4; R&D systems 25ng/ml) 
and heparin (Sigma, 1μg/ml). Conditioned media was prepared by incubating 10ml TS 
medium with 2 x 106 cells 40 Gy irradiated Mefs on 100 mm plates for at least 72 hours. 
Media was filtered (0.2 µm) before storing at -20 C. Primary embryonic fibroblasts were -
derived from 12.5 dpc embryos and cultured in high-glucose DMEM supplemented with 
10% foetal bovine serum (FBS; Globepharm, Esher, UK), 2 mM L-glutamine and antibiotics, 
grown until 80-85% confluence, dissociated with trypsin-EDTA before irradiation. To 
induce TS differentiation cells were seeded at low density and supplements (Fgf4, heparin 
and 70% MEF conditioned media) were withdrawn for 4 days.  An E14Tg2a -derived ES 
cell line (strain 129/Ola) - ZHBTc4 containing a TET OFF inducible Oct4 cassette and 
disrupted endogenous Oct4 loci was obtained from Austin Smith (Wellcome Trust Centre 
for Stem Cell Research, University of Cambridge) and is used throughout this investigation 
(Niwa et al., 2000). Oct4 repression in ZHBTc4 was induced by addition of doxycycline 
(Sigma) at 1μg/ml. TSL-like cells were -derived from ZHBTc4 by incubation with 
doxcycline, plating at low density (1 x 103/ 10 cm2 on irradiated feeders and provision of 
37ng/ml Fgf4 and heparin (1μg/ml) propagation in culture selected for cells that 
underwent differentiation giving rise to a pure population. ZHBTc4 cells were maintained 
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in an undifferentiated state on gelatin-coated surfaces in Glasgow Modified Essential 
Medium-BHK21 medium plus 15% fetal calf serum (FCS), non-essential amino acids, 
sodium pyruvate (1mM), sodium bicarbonate (0.075%), penicillin/streptomycin 
(100U/ml), L-glutamine (292µg/ml), 2-mercaptoethanol (0.1mM) and 1000U/ml of 
recombinant leukemia inhibitory factor (ESGRO-LIF). All mammalian cells were cultured at 
37°C and 5% CO2. 
Drosophila Melanogaster S2 cells (Schneider, 1972) were maintained in Schneider's 
Medium supplemented with 10% heat-inactivated serum and penicillin/streptomycin at 
room temperature. Unless otherwise stated all cell cultures reagents were sourced from 
Gibco®. 
2.2  Embryo collection and dissection 
Pre-pubescent CBAB6 F1 females were super-ovulated by intrauterine injections of 
PMSG (5U Folligon®) followed 42 hours later by HCG (5U Chorulon®) and mating 
overnight with CBA/B6 F1 males. To obtain blastocysts morulae were flushed from uteri at 
2.5 dpc in EmbryoMax® M-2 (Millipore) and cultured overnight to form blastocysts in 30μl 
droplets of equilibrated EmbryoMax® M-16 (Millipore) under mineral oil. TE samples 
were acquired using Leica manual manipulators and a holding pipette to immobilise the 
embryo and micro-dissection blades (Bioniche) to physically dissect away mural TE on a 
Nikon Diaphot with DIC optics. Individual ICMs were isolated by immunosurgery on a 
Nikon SMZ dissection microscope, using rabbit anti-mouse serum, guinea-pig complement 
and acidified Tyrode’s solutions (Sigma) and a finely pulled pipette as previously described 
(O'Neill et al., 2006). To obtain 8-cell embryos uteri were flushed at 2 d.p.c and compacted 
morulae were collected at 2.5 d.p.c and snap frozen before ChIP analysis. 
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2.3 Chromatin immunoprecipitation 
2.3.1 Histone modification ChIP 
Approximately 1x107 exponentially growing cells were harvested, washed twice in 
PBS and cross linked with 1% PFA for 10 min at room temperature. After quenching of PFA 
with glycine at a final concentration of 125 mM for 10 min, cells were washed twice with 
ice-cold PBS and lysed in 1 ml of ice cold lysis buffer (50 mM Tris-HCL pH 8.1, 10 mM EDTA 
pH 8.0, 1% SDS) with protease inhibitor cocktail (Roche). Using a BioruptorTM 200 
(Diagenode, SA, Liège, Belgium), the chromatin was sonicated to an average size of 300 to 
1000 bp as analysed on 1.5% agarose gels. Insoluble proteins were discarded after 
centrifugation of the lysate at 15 000 rpm for 15 min at 18˚C and DNA concentration 
quantified using a spectophotometer . 100-150 µg of fragmented chromatin was diluted 
1/10 in dilution buffer (1% Triton X-100, 2 mM EDTA pH 8.0, 150 mM NaCl, 20 mM Tris-
HCL pH 8.1) with protease inhibitors and incubated at 4˚C for 2 hours, with 30 µl of 
blocked protein A-sepharose beads to pre-clear the solution of any non-specific binding. 
Beads were overnight blocked at 4ºC in dilution buffer supplemented with 10 µl of BSA 
(New England Biolabs, 10 mg/ml) and 4 µl salmon sperm DNA (10 mg/ml) and then 
resuspended in dilution and lysis buffer in a 10:1 ratio. Pre-cleared chromatin was then 
immunoprecipitated (4°C, overnight) with primary antibodies; 5µl anti-dimethyl-H3K4 
(07–030; Millipore), 5µl anti-trimethyl H3K4 (;Abcam), 5µl anti-trimethyl-H3K9 (07-442; 
Millipore),  7.5 µl anti-trimethyl-H3K27 (07–449; Millipore), 2µl of a rabbit anti-mouse-IgG 
antiserum (negative-control; Dako Inc.,) and 5µg of anti-H3-carboxy terminal antibody 
(1791; Abcam) for data normalization, on a spinning wheel. Immune-complexes were 
collected by adding 30 μl of blocked beads once again and left immunoprecipitating 2 
hours on a spinning wheel, at 4ºC. Unbound chromatin was removed by washing four times 
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in 1 ml of cold wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM 
Tris.Cl pH 8.1 and protease inhibitors) and once in final high salt wash buffer (0.1% SDS, 
1% Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris.Cl pH 8.1 and protease 
inhibitors). After adding elution buffer (1% SDS, 0.1 M NaHCO3) to elute the 
immunocomplexes from the beads, these were treated with 100 µg/ml RNase A and 500 
µg/ml PK, 2 hours at 37ºC and 6 hours of incubation at 65ºC to reverse the cross-links. 
Finally, the DNA was sequentially extracted with phenol/chloroform/Isoamylalcohol and 
precipitated in 50% isopropanol containing 5 mM NaAc and 20 µg of glycogen carrier 
(Glycoblue, Ambion). After purification, DNA was resuspended in 100 µl of TE buffer.  
Modified histone levels were normalised against detected H3, and expressed as relative 
enrichment (fold over H3). 
2.3.2 RNA polymerase and chromatin modifier ChIP  
This protocol used has previously been described by (Stock et al., 2007). Cells were 
treated with 1% formaldehyde (37°C, 10 min) and quenched with 125mM glycine (5 min, 
room temperature). Cells were washed in ice-cold PBS and lysed at 4°C for 10 mins (25 
mM HEPES pH 7.9, 1.5 mM MgCl2, 10 mM KCl and 0.1% NP-40). Cells were scraped from 
flasks, nuclei extracted by homogenization, resuspended (50 mM HEPES pH 7.9, 140 mM 
NaCl, 1mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate and 0.1% SDS) and sonnicated. 
Buffers were supplemented with 5 mM NaF, 2 mM Na3VO4, 1 mM PMSF, and protease 
inhibitor cocktail (Roche). Between 500-700µg of fragmented chromatin was subjected to 
immunoprecipitation with 10µl non-phosphorylated RBP1 CTD 8WG16 (MMS-126R; 
Covance), 10µl Ser5 phosphorylated RBP1 CTD4H8 (05-623; Millipore), 10µl Ring1b 
(courtesy of Haruhiko Koseki) and 10µl Suz12 (Pab-029-050; Diagenode). After elution 
and precipitation final DNA concentrations were determined by PicoGreen fluorimetry 
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(Molecular Probes, Invitrogen) and 0.5ng of immunoprecipitated and input DNA were 
analyzed by quantitative real-time PCR (qPCR) and expressed as relative enrichment (fold 
over input). 
2.3.3 Carrier  ChIP 
This protocol was developed and described by (O'Neill et al., 2006) some 
modifications are included. D. melanogaster S2 cells (5 107 cells/ml) were mixed with 10 
Inner Cell Mass, 10 Trophectoderm or 20 Morula samples and washed in NB buffer (15 mM 
Tris-HCL, pH 7.4, 60 mM KCl, 15 mM NaCl, 5 mM MgCl2, 0.1 mM EGTA, 0.5 mM 2-
mercaptoethanol, 0.1 mM PMSF) supplemented with 5 mM sodium butyrate.  Samples 
were resuspended in NB buffer 0.5% Tween-40 and stirred for 1 h at 4°C. Nuclei were 
released by homogenization in a Dounce all-glass homogenizer until approximately 80% 
intact nuclei were observed under the microscope. Nuclei were pelleted, resuspended in 
NB buffer plus 5% (vol/vol) sucrose, pelleted and resuspended in digestion buffer (50 mM 
Tris-HCl pH 7.4, 0.32 M sucrose, 4 mM MgCl2, 1 mM CaCl2, 0.1 mM PMSF). DNA 
concentration was measured, 5U of micrococcal nuclease (GE Healthcare) per 2.5µg of 
chromatin was added and samples incubated at 28°C for a maximum of 5 mins. Samples 
were spun at 1,800g, supernatant removed and stored at 4°C. The pellet was resuspended 
in 500µl-1 ml lysis buffer (2 mM Tris-HCl, pH 7.4, 0.2 mM EDTA, 5 mM sodium butyrate, 0.2 
mM PMSF, 0.4 mM glycine) and dialyzed overnight at 4°C against lysis buffer, centrifuged. 
Supernatants and pellet were analyzed by agarose gel electrophoresis. If the chromatin 
was satisfactory (mainly mono, di and tri nucleosomes) supernatants were combined and 
used for ChIP.  Samples were incubated in (50 mM NaCl, 20 mM Tris–HCl, pH 7.5, 20 mM 
Na butyrate, 5 mM Na2EDTA, 0.1 mM PMSF) with 15µl anti-trimethyl-H3K27 (07–449; 
Millipore), 50µl anti-trimethyl-H3K4, 75µl anti-acetyl-H4K16, pre-immune 25µl  (courtesy 
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of Laura O’Neill) or 15µl anti-trimethyl-H3K9me3 (07-442; Millipore) rotating at 5 rpm 
overnight at 4°C.  Protein A sepharose (GE healthcare) was added to immobilize 
chromatin-antibody complexes samples rotated for 3 hours at room temperature. The 
supernatant of centrifuged samples were kept on ice; reflecting the unbound fraction of 
input chromatin. Bound fractions were washed in progressively stringent buffers 50-
150mM NaCl. Elution was carried out for 30 mins at room temperature (50 mM NaCl, 
20 mM Tris–HCl, pH 7.5, 20 mM Na butyrate, 5 mM Na2EDTA, 0.1 mM PMSF, 1% SDS). 
Proteinase K 0.2mg/ml (Sigma) was added to both unbound and bound fractions and 
incubated at 50°C for 2 hours. DNA was isolated using a Qiaquick gel extraction kit 
(Qiagen) and resuspended in 50-60µl TE. DNA concentrations were determined by 
PicoGreen fluorimetry (Molecular Probes, Invitrogen) and unbound fractions were further 
diluted in TE to match bound concentrations before analysis by quantitative real-time PCR 
(qPCR) and expressed as relative enrichment (bound/unbound ratio).. 
2.4 Methylated DNA immunoprecipitation analysis (MeDIP) 
MeDIP was carried out using genomic DNA from ES, TS and TSL as previously 
described (Weber et al., 2005). Genomic DNA was isolated from cells by overnight 
incubation in 500 µl of Lysis buffer (200 mM NaCl, 100 mM Tris-HCl pH 7.4, 5 mM EDTA, 
0.2% SDS, 250 µg PK) at 55ºC and subsequent phenol/chlorophorm/isoamylalcohol and 
chlorophorm/isoamylalcohol extractions. DNA was then precipitated with 50% 
isopropanol, followed by 70% ethanol wash, and resuspension in TE with 20 µg/ml 
RNAseA. DNA concentration was determined using a NanoDrop  ND-1000. Genomic DNA 
was sonicated (VC 130 PB, Sonics & Materials, Inc) to produce random fragments ranging 
in size from 300 to 1000 bp. 5 µg of fragmented DNA was used for the MeDIP assay. After 
denaturation for 10 min at 95 C and cooling down on ice for 2 min, samples were 
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immunoprecipitated for 2 hours at 4 C with 10 µl of Methyl-C antibody in a final volume of 
500 µl of immunoprecipitation buffer (10 mM Na-Phosphate pH 7.0, 0.14 M NaCl, and 
0.05% Triton X-100) with constant rotation. Chromatin-antibody complexes were then 
precipitated with 30 µl of Dynabeads® with M-280 sheep antibody against mouse IgG 
(Dynal Biotech, Oslo, Norway) for 2 hours at 4 C and washed three times with 700 l of 
immunoprecipitation buffer. Beads were then treated with 70 µg of PK for 3 hours at 50 C 
and methylated DNA was recovered by phenol-chloroform extraction followed by ethanol 
precipitation at -20 C and resuspended in 60 µl of TE buffer. The abundance of methylated 
DNA was determined by qPCR amplification with 25 ng of input DNA and 2 µl of the 
immunoprecipitated methylated DNA and expressed as relative enrichment (fold over 
input). 
2.5 Reverse transcription and real time quantitative polymerase chain 
reaction 
2.5.1 RNA extraction and cDNA synthesis 
 RNA extraction was performed using RNeasy protect mini kit (Qiagen, Valencia, 
CA) for cell lines and micro kit for embryos, residual DNA eliminated with RNase-free 
DNase set (Qiagen) according to manufacturer’s instructions. RNA was then reverse 
transcribed using the SuperscriptTM first-strand synthesis system (Invitrogen). 1.5 µg of 
total RNA was diluted in Rnase free water to a final volume of 11 µl and supplemented with 
1 µl of 10 mM dNTP mix (Invitrogen) and 1 µl of oligo (dT)12-18 (Invitrogen). The mixture 
was incubated at 65°C for 5 min and put on ice for 1 min, when 1 µl of 0.1 M DTT, 4 µl of 5X 
first strand buffer, 1 µl of RnaseOUT (Invitrogen) and 1 µl of 200 U/µl Superscript III were 
added. A reaction mixture without the enzyme was also set up as a control (designated “-
Page | 50 
 
RT”). The mixture was then incubated at 50°C for 1 hour and at 70°C for 15 min in order to 
stop the reaction. 180 µl of RNase-free water was then added to each cDNA sample.  
2.5.2 Primer design and testing for quantitative PCR 
 ChIP primers were designed with the Primer Express software (Applied 
Biosystems, Warrington, UK) while gene expression primers designed with PerlPrimer 
software (Marshall, 2004) using sequences from the mouse and human Ensemble Genome 
Browser (http://www.ensembl.org/index.html) database. The following design criteria 
were used: amplicon size of 100-200 bp, GC content of 40-60%, melting temperature 55-
65°C. All primer pairs were tested for predicted products using in silico PCR tools such as 
PUNS (http://okeylabimac.med.utoronto.ca/PUNS) or the UCSC genome browser 
(http://genome.ucsc.edu). Primers yielding a single predicted PCR product of the correct 
size were ordered from Sigma Genosys. The efficiency of amplification for each primer pair 
was determined by qPCR with sequential dilutions of cDNA or genomic DNA (see section 
2.2.10.1. further on) and primers yielding poor linear fits of the C(T) versus logarithm of 
concentration (R2<0.98) or efficiencies lower than 1.8 or greater than 2.2 were discarded. 
When species specificity was required (i.e. analysis in C-ChIP), primers were designed and 
tested to specifically amplify the mouse sequences but not the Drosophila orthologs 
2.5.3 Real-time quantitative PCR analysis (qPCR) 
 Real-time PCR analysis was performed in 30 µl reaction volume with Jumpstart 
Sybr-Green PCR Mastermix (Sigma), 300 nM primers and 2 µl of template. A reaction 
without DNA was included to control for the formation of primer dimers and each 
measurement was performed in duplicate. PCR reactions were carried out on a DNA 
Engine OpticonTM II using Opticon Monitor 3 software (MJ Research Inc., Waltham, MA), 
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running the following program: an initial denaturating step at 95°C for 15 min, 40 cycles of 
denaturation at 94°C for 15 sec, annealing at 60°C for 30 sec, elongation at 72°C for 30 sec 
at which point the fluorescence was read at 72°C, 75°C, 78°C, 80°C and 83°C. The melting 
curve was determined from 70°C to 90°C, at 0.1°C intervals. For analysis of the qPCR data 
the relative abundance of sequences was calculated using the C(T) method, examples of 
raw data manipulation are shown below (Pfaffl et al., 2001). Gene expression data was 
normalized to the average of two housekeeping genes; Actin and L19 as previously 
described (Vandesompele et al., 2002). Primer sequences used in this study for gene 
expression and ChIP analysis can be found in Appendix I. 
 
Table I. Examples of qPCR calculations used to measure mRNA expression levels, fold 
enrichment over input after ChIP and the ratio of bound over unbound sequences after 
CchIP experiments. 
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2.6 Western blotting  
Whole cell protein extracts were obtained after washing in PBS by cell lysis in 
protein extraction buffer (Na3PO4 20mM, NaCl 137mM, sodium beta-glycophosphate 
25mM, sodium pyrophosphate 2mM, EDTA 2mM, Glycerol 10%, Triton X100 1% and 
protease inhibitor cocktail, Roche) on ice for 30 mins. Samples were centrifuged and 
supernatant taken and stored at -20°C. Protein concentrations were measured using the 
Bradford assay (Thermo Fisher Scientific) and readings taken from Optimax tunable 
microplate reader (Molecular devices). Protein samples were diluted 1:1 with Laemmli 
sample buffer (BioRad) with 5% β-mercaptoethanol and heated at 95˚C for 5 min, 20 -30 
µg were loaded onto 10% acrylamide gels and electrophoresed for 1 hour at 200V. Gels were 
blotted onto methanol activated polyvinylidene fluoride membranes (Chemicon/Milipore) 
using a semi-dry transfer system for 1 hour at 20V. The membranes were then blocked with 5% 
skimmed milk (Sigma) in Tris-Buffered Saline with 0.5% Tween20 (TBS-T) for 1 hour at 
room temperature, followed by primary antibody incubation (Ring1B 1:1000; Suz12 
1:2000) diluted in blocking buffer or 5% BSA in TBS-T, overnight at 4˚C, with agitation. 
Membranes were washed, to remove any excess antibody, for 10 min three times in TBS-T 
under agitation before incubating with the appropriate HRP-conjugated secondary 
antibody (Santa Cruz; 1:5000) in blocking buffer, for 1 hour at room temperature. Excess 
secondary antibody was then removed by washing the membrane for 10 min three times 
in TBS-T buffer (50mM Tris Base, 0.9% NaCl, 0.05% Tween 20, pH 7.6) under agitation. 
After washing the blot was treated by enhanced chemiluminescence (ECL) western 
blotting detection reagents (Amersham Pharmacia Biotech, Little Chalfont, UK) for HRP-
conjugated antibody detection before being exposed to X-ray films (CL-XPosure Film, 
Thermo Scientific, UK) and using the OPTIMAX IGP developer. 
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2.7 Immunofluorescence analysis 
Cells were seeded on glass coverslips for at least 4 hours, fixed in PBS with 4% 
paraformaldehyde for 10 mins at room temperature. Slides were washed in PBS before 
incubation in blocking and permeablisation buffer (10% Normal Goat Serum and 0.4% 
Triton X and bovine serum albumin) for at least 30 minutes at room temperature. Samples 
were again washed in PBS before incubation at room temperature with primary antibodies 
anti-Oct4 (Santa-Cruz), anti-Cdx2 (Biogenex), anti-Nanog (Cosmo-Bio), anti-Sox2 (Abcam), 
anti-Ring1B (courtesy of Haruhiko Koseki) or anti-Suz12 (Upstate) for 1 hour. After 
subsequent washes in PBS samples were incubated with Alexa Fluor® 488/568 goat a-
mouse/rabbit IgG H+L (Molecular probes) for 1 hour at room temperature. Coverslips 
were mounted on Vector shield with DAPI (Vector labs) and examined using a Nikon E600 
microscope or Leica SP5 confocal microscope. 
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Chapter 3 –Results  
 
 Analysis of bivalent chromatin signatures in ES and TS cells. 
 
During blastocyst formation the inner cell mass of a pre-implantation embryo 
safeguards pluripotency while surrounding cells differentiate into an extra-embryonic 
restricted layer, the trophectoderm. As shown in Figure 3.1 Embryonic stem (ES) cells -
derived from the ICM retain the pluripotency of their cognate lineage and are able to 
differentiate into all three germ layers of the embryo but are generally excluded from the 
trophoblast lineage. TE-restricted trophoblast stem (TS) cells are, in contrast, more limited 
in their developmental potency and contribute solely to placenta formation in vivo 
(Rossant and Tam, 2009).  
 
Figure 3.1. The early mouse blastocyst and embryo-derived stem cell lines. Schematic 
representation of mouse pre-implantation blastocyst depicting the pluripotent inner cell 
mass (green) and extra-embryonic restricted trophectoderm layer (orange). Light 
microscopy images illustrate the morphology of ICM-derived ES cells and TE-derived TS 
cells, both are used throughout this study. Generation of chimeras using embryonic versus 
extra-embryonic stem cells demonstrates the cells distinct developmental potential; in vivo 
images are courtesy of T. Kunath.   
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In 2006 a number of research groups undertook to identify genomic binding sites 
of polycomb proteins in ES cells. Interestingly the majority of newly discovered targets 
encode transcriptional regulators such as Sox, Fox, Pax, Irx or Pou family members, many 
of which are involved in developmental patterning such as segmentation, eye and limb 
development, indicating that PcG proteins play a major role in orchestrating such 
pathways (Boyer et al., 2006b; Lee et al., 2006; Schuettengruber et al., 2007). Another 
unexpected finding was revealed by concomitant studies analysing the chromatin 
environment of key development gene promoters and highly conserved non coding 
elements (HCNE) in ES cells (Azuara et al., 2006; Bernstein et al., 2006a). In ES cells many 
PcG bound, H3K27me3 positive loci were also shown to be marked by trithorax mediated 
H3K4 methylation. Such regions were described as bivalent chromatin domains and have 
been proposed to prime a gene for expression later in development while preventing 
premature transcription, creating a bipotential state (Azuara et al., 2006; Bernstein et al., 
2006a). ES cells lacking H3K27 tri-methylation due to genetic disruption of the PRC2 
components Eed or Suz12 show inappropriate expression of developmental regulators 
supporting the hypothesis that bivalent chromatin domains function to keep loci primed 
for transcriptional activation (Azuara et al., 2006; Bernstein et al., 2006a; Boyer et al., 
2006b; Lee et al., 2006). Together these studies demonstrated that polycomb-mediated 
gene repression can provide a short-term, and therefore flexible, epigenetic silencing in 
pluripotent cell lines (Azuara et al., 2006; Bernstein et al., 2006a; Boyer et al., 2006b; Lee et 
al., 2006). The discovery of poised developmental regulators in pluripotent ES cells is an 
exciting concept; however, the functional significance of such domains is not yet clear. In 
the following experiments I assessed whether bivalent chromatin domains are a unique 
attribute of pluripotent cells in the early embryo.   
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3.1 Bivalent chromatin domains mark the promoters of silent, lineage- 
inappropriate genes in TS cells. 
In this analysis I compare a previously established extra-embryonic restricted 
trophoblast stem (TS) cells (B1) supplied by N.Brockdorff to an E14Tg2A -derived ES cell 
line denoted ZHBTc4 (kindly provided by H. Niwa) (Mak et al., 2002; Niwa et al., 2000). 
These contrasting cell lines display different morphology in culture (as depicted in Figure 
3.1) and exhibit distinct growth factor requirements to maintain an undifferentiated state. 
Provision of Fibroblast growth factor 4 (Fgf4), heparin and primary mouse embryonic 
fibroblasts supports TS self-renewal while ES cells depend upon 0.1% gelatin and 
Leukemia inhibitory factor.  
To characterise the chromatin environment of key developmental regulators in 
lineage restricted TS cells chromatin-immunoprecipitation (ChIP) was employed.  ChIP is a 
powerful tool commonly harnessed to monitor in vivo distribution of histone modifications 
and chromatin interacting factors. TS and ES cell lines were expanded and fixed in 1% 
formaldehyde preserving protein-DNA interactions of both histone and non-histone 
proteins. Extracted chromatin was sonicated giving rise to an average fragment size 
between 300-500bp and incubated with specific antibodies against H3K4me2, H3K27me3, 
H3 c-terminal and IgG (used a negative control). High temperatures and enzymatic 
digestion were used to destroy immunoprecipitated histones enabling the purification of 
associated DNA for analysis. qPCR primers were designed to amplify up to 600bp upstream 
of a candidate gene’s transcriptional start site (Appendix I).  Levels of modified histones 
were monitored and potential differences in nucleosome density were accounted for by 
normalising to corresponding levels of detected H3. Levels of unspecific antibody binding 
and DNA precipitation were reflected by inclusion of an IgG control, biological duplicates 
or triplicates were used in each ChIP experiment.     
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For this analysis a panel of candidate loci was selected based on previously 
published data, each promoter had been shown to be marked by bivalent domains in ES 
cells and were more recently revealed as joint PRC2 and PRC1 targets (Ku et al., 2008). 
Although chosen loci (listed in Table II) exhibit similar properties within their promoters 
regions, a variety of transcriptional regulators (Flk1, Gata4, Hoxa7, Math1, Mixl1, Pax3, Sox1 
and Sox7) covering a number of different lineages, as well as TS-associated markers (Cdx2, 
Fgfr2 and Hand1) are included in the analysis. Genetic inactivation of these selected genes 
commonly results in embryonic lethality (Table III). 




Symbol Protein encoded Lineage affiliation * Chr 
CpG 
class 
 H3K27me3  PRC2  PRC1  
& H3K4me2 target target 
Cdx2 Homeobox transcription factor Extra-embryonic 5 HCP Yes Yes Yes 
Fgfr2 Tyrosine kinase receptor Diverse 7 HCP Yes Yes Yes 
Hand1 Basic helix-loop-helix transcription factor Extra-embryonic 11 HCP Yes Yes Yes 
Flk1 Tyrosine kinase receptor Mesoderm 5 HCP Yes Yes Yes 
Pax3 Paired domain transcription factor Mesoderm 1 HCP Yes Yes Yes 
Math1 Basic helix-loop-helix transcription factor Ectoderm 6 HCP Yes Yes Yes 
Sox1 High mobility group (HMG) box transcription factor Ectoderm 8 HCP Yes Yes Yes 
Hoxa7 Homeobox transcription factor Mesoderm 6 HCP Yes Yes Yes 
Mixl1 Paired-like homeobox transcription factor Mesoderm 1 HCP Yes Yes Yes 
Gata4 Ainc-finger transcription factors Endoderm 14 HCP Yes Yes Yes 
Sox7 High mobility group (HMG) box transcription factor Endoderm 14 HCP Yes Yes Yes 
 
Table II. Genes selected for candidate-based epigenetic analysis in ES and TS cells their protein functions and promoter features. Gene symbols 
and location information are stated as reported within Ensembl (Hubbard et al., 2009) .* Lineage affiliation reflects tissues in which genes are pre-
dominantly expressed in accordance with UniGene cDNA libraries (Wheeler et al., 2003). H3K27me3, H3K4me2 and high CpG status (HCP) status were 









Gene name Gene inactivation phenotypes References 
Caudal type homeo box 2 Defective blastocoel cavity formation, no implantation (Strumpf et al., 2005) 
Fibroblast growth factor receptor 2 Lethality at 10.5 d.p.c, defect in chorioallantoic fusion and trophoblast cell proliferation (Xu et al., 1998) 
Heart and neural crest derivatives expressed transcript 1 Lethality at 7.5 d.p.c, defect in trophoblast giant cell differentiation (Riley et al., 1998) 
Vascular endothelial growth factor receptor-2 Lethality at 8.5-9.5 d.p.c, defect in the development of haematopoietic and endothelial cells. (Shalaby et al., 1995) 
Paired box gene 3 Mid-gestational lethality, defects in myogenesis, neural tube closure and neural crest lineages. (Mansouri et al., 2001) 
Atonal homolog 1 Born alive, but a few minutes after birth, defective cerebellum (Ben-Arie et al., 1997) 
SRY-box containing gene 1 Viable, defects in ventral telencephalic development – epilepsy (Malas et al., 2003) 
Homeo box A7 Viable, compound HoxA/B7 exhibit first and second rib defects (Chen et al., 1998) 
Mix1 homeobox-like Developmental arrest at 9 dpc  - abnormal germ layer morphogenesis during gastrulation (Hart et al., 2002) 
GATA binding protein 4 Lethality at 9.5 d.p.c profound defects in ventral morphogenesis (Narita et al., 1997) 
SRY-box containing gene 7 Not yet studied N/A 
 
Table III. Candidate gene names, associated in vivo gene inactivation phenotypes and key references.




Figure 3.2. H3K27me3 and H3K4me2 mark embryonic-associated loci in TE-derived 
stem cells. Relative enrichment of H3K27me3 and H3K4me2 at a panel of selected 
promoters in ZHBTc4-ES (green bars) and B1-TS (orange bars) cells. Background levels 
(from control IgG antibodies) are shown as grey bars. Enrichment is expressed relative to 
H3. Data shown is representative of 3 experiments, error bars represent s.d. Expression 
status is shown here as an aid, actively transcribed genes are marked (+) graphical 
representation is shown in Fig 4.4. 
As shown in Figure 3.2 and consistent with previously published data significant 
levels of both repressive H3K27me3 and permissive H3K4me2 were observed in ES cells at 
the selected panel of silent developmental regulators (Cdx2, Fgfr2, Hand1, Flk1, Pax3, 
Math1, Sox1, Hoxa7, Mixl1, Gata4 and Sox7). In contrast, actively expressed Actin showed 
enrichment for H3K4me2 and low levels of H3K27me3 as expected, while the negative 
control region (Inter.) showed little enrichment for either histone modification (Figure. 
3.2). TS cells express 5 of the 11 candidate genes selected for analysis Cdx2, Fgfr2, Hand1, 
Flk1 and Pax3 consistent with their transcriptional status H3K4me2 levels were prominent 
at promoters while only low levels of H3K27me3 were observed. In contrast, Math1, Sox1, 
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Hoxa7, Mixl1, Gata4 and Sox7 are not expressed in TS cells and accordingly show high 
levels of repressive H3K27me3. Surprisingly these silent genes were also marked by 
H3K4me2 in extra-embryonic restricted TS cells, while control genes (Actin and Inter.) 
show the same profile as ES cells.  
Although TS cells are able to give rise to diverse cell types within the placenta there 
was little evidence to suggest that Math1, Sox1, Hoxa7, Mixl1, Gata4 and Sox7 are activated 
during trophoblast maturation and placental development. To verify whether genes 
marked by bivalent domains in TS cells (Math1, Sox1, Hoxa7, Mixl1, Gata4 and Sox7) are 
activated upon placenta formation RNA was extracted from placenta samples and analysed 
by qRT-PCR. Expression of Cdx2, Fgfr2, Hand1, Flk1 and Pax3 were all detectable consistent 
with their expression in TS cells. However, transcriptionally silent genes marked by H3K4 
and H3K27 methylation in TS cells showed little expression in this tissue (Figure 3.3). Why 
these lineage-inappropriate silent genes are marked by conflicting histone modifications in 
TS cells was a perplexing question.  
 
Figure 3.3. Candidate gene expression in the developing placenta. RNA levels of 
candidate genes were measured by qRT-PCR in placenta 12.5 dpc Data was obtained from 
3 independent experiments, normalised to housekeeping genes Actin and L19 and 
expressed relative to control tissues: TS cells-Cdx2, Fgfr2, Hand1 and Flk1, heart-Pax3, 
intestine-Math1, embryonic head-Sox1, kidney-Hoxa7, embryoid bodies-Mixl1, XEN cells-
Gata4 and Sox7. 
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Figure 3.4. Bivalent domains mark key embryonic regulators in extra-embryonic TS 
cells. Sequential ChIP using first anti-H3K27me3 followed by anti-H3K4me2 antibodies in 
ES and TS cells. Enrichment is expressed relative to H3. Data shown is representative of 3 
experiments, error bars represent s.d. Expression status is shown here as an aid, actively 
transcribed genes are marked (+). (These experiments were carried out in collaboration 
with A. Helness) 
  
To confirm the presence of methylated H3K27 and H3K4 at the same chromosomal 
region in TS cells and thus rule out the possibility of differential loci marking within the 
cell population, a sequential chromatin-immunoprecipitation (ChIP) was performed. 
Chromatin was extracted from TS cells (and ES cells as controls) and incubated initially 
with H3K27me3 antibody, the resulting eluate was then exposed to H3K4me2 antibody. 
Consequently only chromatin associated with both H3K27me3 and H3K4me2 were 
enriched in the final precipitate, while promoters occupied by H3K27me3 or H3K4me2 
only were lost.  Consistently Math1, Sox1, Hoxa7, Mixl1, Gata4 and Sox7 were precipitated 
at a much higher frequency by sequential ChIP than either actively expressed Actin marked 
only by H3K4me2 or the intergenic region (Inter.) marked by neither histone modification 
(see Figure 3.4). Selected developmental regulators were all proven as bivalent in ES cells, 
in agreement with previously published data (Mikkelsen et al., 2007). Data from this 
experiment validates H3K27me3 and H3K4me2 co-occupancy of Math1, Sox1, Hoxa7, Mixl1, 
Gata4 and Sox7 promoters regions on a single allele and confirms conventional ChIP data. 
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Thereby defining the bivalent status of these developmental regulators in TE restricted 
stem cells. 
 Sequential ChIP was also conducted in the reverse orientation; first incubating 
chromatin with H3K4me2 followed by H3K27me3 antibodies. However, high background 
levels were observed most likely due to higher binding affinity of H3K4me2 for which the 
elution conditions previously used between antibody incubations proved insufficient. This 
resulted in amplification of active gene promoters such as Fgfr2, despite no previous 
indication of H3K27me3 occupancy at this locus in TS cells (Appendix II).  
3.2 Both H3K4me2 and H3K4me3 occupy bivalently marked loci in TS 
cells. 
 Genome-wide studies in ES cells have shown a high correlation between H3K4me2 
and H3K4me3 occupancy (Barski et al., 2007). H3K4me3 was shown to occupy sequences 
close to transcriptional start sites (TSS) resulting in a sharp peak. In contrast, H3K4me2 
was often observed to occupy a more diffuse domain stretching to form a platform around 
a gene’s TSS (Barski et al., 2007). Although patterns of H3K4me2 and H3K4me3 occupancy 
are very similar in ES cells these histone modifications have been shown to display more 
disparate distribution patterns upon differentiation of multipotent hematopoietic 
progenitors (Orford et al., 2008). In light of these studies I compared the status of 
H3K4me3 occupancy at candidate gene promoters in ES and TS cells, to examine whether 
changes in H3K4 methylation accompanies lineage commitment in the early embryo. In ES 
cells H3K4me2 and H3K4me3 enrichment are evident throughout the panel of 
developmental regulators, as expected. Actively transcribed genes Cdx2, Fgfr2, Hand1, Flk1, 
Pax3 and control gene Actin are also enriched for H3K4me3 in TS cells, as anticipated. 
Silent genes previously shown to harbor H3K4me2 (Math1, Sox1, Hoxa7, Mixl1, Gata4 and 
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Sox7) were shown here to be equally enriched for H3K4me3. This data suggests that, 
unlike multipotent hematopoietic progenitors, differential H3K4 methylation states do not 




Figure 3.5. Comparison of H3K4me2 and H3K4me3 levels at promoter regions of key 
developmental genes in ES and TS cells. Relative enrichment of H3K4me2 and H3K4me3 
at a panel of selected promoters and controls in ZHBTc4-ES (green bars) and B1-TS 
(orange bars) cells. Background levels (from control IgG antibodies) are shown as grey 




Page | 65 
 
3.3 TS cell differentiation does not induce loss of permissive H3K4 
methylation at lineage-inappropriate genes.  
TS cells are a self-renewing and multipotent population if we suppose that bivalent 
domains undergo gradual resolution over a series of smaller lineage restriction events; we 
assume that terminal differentiation of TS cells would induce depletion of H3K4 
methylation at promoters of lineage-inappropriate genes. To test this hypothesis Fgf4 and 
Mef conditioned media were withdrawn from cultures for 4 days. Fgf4 regulates TS cell 
self-renewal, in absence of this growth factor and supportive Mef conditioned media cells 
predominantly differentiate into a mixture of spongiotrophoblasts and trophoblast giant 
cells (Erlebacher et al., 2004; Tanaka et al., 1998).   
Consistent with published studies expression levels of Cdx2 and Fgfr2, markers of 
self-renewing trophoblast, were down-regulated by day 4 while spongiotrophoblast 
associated Tpbpa and trophoblast giant cell marker Pl1 were notably induced (Figure 
3.6A). TS cell morphology altered, cytoplasm flattened and extended while a combination 
of cell fusion and endoreplication resulted in the formation of polyploid cells (Figure 3.6B). 
After 4 days in differentiation conditions both di and tri-methyl H3K4 remain associated 
with lineage-inappropriate promoters, showing that further restriction of developmental 
potency in TE-derived stem cells is not accompanied by a loss of H3K4me2 and H3K4me3 
at silent, lineage-inappropriate genes (Figure 3.6C).  
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Figure 3.6. Differentiated TS cells harbour H3K4me2 and H3K4me3 at lineage-
inappropriate genes. TS cell differentiation was induced by FGF4, heparin and primary 
embryonic fibroblast conditioned media withdrawal over four days. (A) mRNA levels of TS 
cell associated genes (Cdx2 and Fgfr2) and differentiation markers (Tpbpa and Pl1) were 
measured by qRT-PCR before (TS; white bars) and after (TSdiff.; black bars) differentiation. 
Data were normalised to housekeeping genes (Actin and L19) and expressed relative to 
undifferentiated TS cells (TS=1). (B) Light microscope images show TS cells under 
maintenance growth conditions (TS) and after four days of differentiation (TSdiff.FGF4). (C) 
Relative enrichment of H3K4me2 and H3K4me3 was assessed at selected loci by ChIP and 
qPCR in TSdiff.FGF4 cells.  Actin and intergenic region (Inter.) are shown as positive and 
negative controls, respectively.  Background levels (from control IgG antibodies) are 
shown as grey bars. Error bars represent s.d. of 2 independent experiments. 
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3.4 PRC1 and poised RNAP II are not recruited to lineage-inappropriate 
genes that retain bivalent domains in TS cells.  
The presence of bivalent chromatin domains at key developmental regulators in 
extra-embryonic committed TS cells was perplexing and seemingly at odds with the idea of 
gene priming. To further explore the status of bivalent genes in TS cells I assessed whether 
additional features of poised chromatin, previously identified in pluripotent ES, are also 
present in extra-embryonic restricted stem cells. In ES cells all candidate loci are targeted 
by both PRC2 and PRC1 complexes (Table II). PCR2 contains three major components; Eed, 
Suz12 and Ezh2, which catalyses tri-methylation of H3K27, disruption of the PRC2 complex 
by deletion of Eed or Suz12 in ES cells causes up-regulation of many genes marked by 
bivalent domains (Azuara et al., 2006; Boyer et al., 2006b). PRC1 contains the E3 ubiquitin 
ligases Ring1A and Ring1B that mono-ubiquitinate histone H2A lysine 119. Other PRC1 
components include Bmi1, Mel18 and proteins of the Cbx family with affinity for H3K27 
methylation (Ringrose and Paro, 2007; Schuettengruber et al., 2007; Sparmann and van 
Lohuizen, 2006). Although Polycomb repressive complex 1 (PRC1) has been shown to 
consolidate silencing by reinforcing PRC2 repression, a functional link has also been shown 
between PRC1 and RNAP II in ES cells. Conditional deletion of Ring1A/B revealed that 
Ring1B restrains RNA Polymerase II (RNAP II) inducing a poised conformation and 
preventing premature expression of genes marked by bivalent chromatin domains (Stock 
et al., 2007).    
  




Figure 3.7. Differential Ring1B recruitment to key developmental genes in ES and TS 
cells. (A) Binding of PRC2 (Suz12) and PRC1 (Ring1B) components was assessed by ChIP 
and qPCR in ES and TS cells at a selected panel of loci. Enrichment is expressed relative to 
input. Data shown is representative of 3 experiments, error bars represent s.d. These ChIP 
experiments were carried in collaboration with A. Helness and E. Brookes (B) Western blot 
analysis using anti-Suz12, anti-Ring1B and anti-tubulin (loading control) antibodies in ES 
and TS cells(C) Immunofluorescence analysis in female B1-TS cells, showing co-localisation 
of Suz12 and Ring1B on inactive X chromosomes in trophoblast cells (white arrows); scale 
bar represents 10 m.  
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To evaluate PRC2 and PRC1 binding in TS cells ChIP was carried out using 
antibodies against Suz12 and Ring1B, respectively. As anticipated from the presence of 
H3K27me3, the PRC2 component Suz12 was found at all bivalent promoters analysed in 
both stem cell populations, although relatively lower levels were seen in TS cells. However, 
in striking contrast to ES cells, silent, Suz12-bound genes were not significantly enriched 
for the PRC1 component Ring1B relative to expressed genes in TS cells (Figure 3.7A). 
Western blot analysis demonstrated that the different patterns of Suz12 and Ring1B 
binding did not correlate with changes in protein levels in the two cell types (Figure 3.7C). 
The presence of Ring1B in TS cells was also verified by immunofluorescence (Figure 3.7D), 
showing co-localisation of Ring1B and Suz12 on the inactive X chromosome of female cells 
as previously seen (de Napoles et al., 2004; Fang et al., 2004)  
 As previously discussed PRC1 and poised RNAP II are functionally linked in ES 
cells, together they are thought to prime bivalent genes for activation while preventing 
their premature expression. In mammals the largest RNAP II subunit has a well-
characterised C-terminal repeat domain (CTD) consisting of 52 copies of the consensus 
repeat heptad Y1S2P3T4S5P6S7 (Corden, 1990).  Hypophosphorylated RNAP II is recruited to 
promoters where the CTD is subject to hyperphosphorylation, a state traditionally 
associated with actively transcribed genes. Ser-2 and Ser-5 residues of the heptad repeat 
are common targets of phosphorylation (P), the transcription pre-initiation complex 
associates with Ser-5P at the 5’ of genes while Ser-2P correlates with transcript elongation 
in the coding region. In ES cells bivalent genes were found to assemble RNA polymerase II 
complexes preferentially phosphorylated on Ser-5 residues however, unlike inducible 
genes such as those belonging to the heat shock family, little hypophosphorylated RNAP II 
could be detected (Guenther et al., 2007; Stock et al., 2007). Unexpectedly RNAP II Ser5P 
was also detected in the coding region of these genes but little evidence of elongation (Ser-
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2 phosphorylation) was found.  This unusual conformation of RNAP II at bivalent genes has 
been described as poised. Release of RNAP II from the poised conformation and up-
regulation of target gene expression in ES cells (from primed to overt transcription) was 
induced in ES cells by conditional deletion of Ring1A/B (Endoh et al., 2008; Guenther et al., 
2007; Jorgensen et al., 2006; Stock et al., 2007) 
To assess whether promoters occupied by opposing histone modifications in TS 
cells are also subjected to transcriptional priming, the recruitment and conformation of 
RNAP II were examined by ChIP using previously validated antibodies against either hypo-
phosphorylated (8WG16) or Ser5-phosphorylated (Ser5P; 4H8) RNAP II (Stock et al., 2007; 
Xie et al., 2006; Xie and Pombo, 2006). As shown in Figure 3.8, bivalent genes and active 
controls (Actin and Hprt) were found highly enriched for Ser5P RNAP II at their promoter 
regions in ES cells. A poised RNAP II conformation was discriminated by measuring the 
level of 8WG16 binding, which was evident at actively transcribed controls, but low at 
bivalent promoters in ES cells as reported (Guenther et al., 2007; Stock et al., 2007). In TS 
cells, Ser5P and 8WG16 both assembled at expressed genes (Cdx2, Fgfr2, Hand1, Flk1 and 
Pax3 ) as well as active controls (Actin and Hprt), as expected (Figure 3.8; right panel). 
RNAP II complexes (Ser5P/8WG16) were, in contrast, absent or barely detectable at the 
promoters of Math1, Sox1, Hoxa7, Mixl1, Gata4 and Sox7 in TS cells. Altogether these data 
indicate that RNAP II complexes and PRC1 do not occupy lineage-inappropriate promoters 
in TE-restricted stem cells. This is consistent with a loss of gene priming, as verified in vivo 
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Figure 3.8. Poised RNA polymerase II is not detected at bivalent loci in TE-derived 
stem cells. Abundance of Ser5 phosphorylated (Ser5P) or hypophosphorylated (8WG16) 
RNAP II at bivalent, active and intergenic loci in ZHBTc4-ES (green bars) and B1-TS 
(orange bars) cells. Enrichment was assessed by ChIP and qPCR and is expressed relative 
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3.5 Markers of trophoblast differentiation - Tbpba and Pl1 do not adopt a 
poised chromatin conformation in TS cells.   
One intriguing question that remained is whether trophoblast related genes adopt a 
poised chromatin conformation in TS cells, or whether this is an epiblast-specific 
phenomenon. Here I examined the promoters of two well-known markers of trophoblast 
differentiation and assess whether hallmarks of gene priming are evident at these loci in 
TS cells.  Two waves of TGC differentiation have been observed in vivo, primary TGCs arise 
from the mural trophectoderm of the blastocyst, which lies away from the ICM. While 
secondary TGC differentiation occurs via progenitor cells in the ectoplacental cone known 
to express trophoblast specific protein alpha (Tbpba). A number of TGCs subtypes have 
been identified and are characterised by expression of placental lactogen (Pl) gene family 
members in different combinations (Simmons et al., 2007). Levels of H3K4me2, H3K27me3 
and RNAP II recruitment were assessed by ChIP and patterns of enrichment were 
compared between ES and TS cells at Tbpba and Pl1 promoters.   
Pluripotent ES cells show little enrichment for methylated H3K4 and H3K27 or 
poised RNAP II at placenta specific genes Tbpba and Pl1; in contrast, Cdx2 and Fgfr2 are 
enriched for both histone modifications and Ser5P RNAP II. Low levels of H3K4me2 and 
H3K27me3 at Tbpba and Pl1 were also observed in TS cells indicating that these loci do not 
adopt a poised conformation prior to differentiation and associated transcription. This was 
further confirmed by the absence of poised RNAP II as assessed by ChIP with 4H8 and 
8WG16 antibodies (Figure 3.9B). Cdx2 and Fgfr2 are active in this cell type and consistently 
show low levels of H2K37me3, while H3K4 methylation and hypophosphorylated RNAP II 
(8WG16) are evident. Both ES and TS cells show enrichment for H3K4 methylation and low 
levels of repressive H3K27me3 at actively transcribed housekeeping gene Actin, while the 
intergenic region shows low levels for both of the modified histones.  





Figure 3.9 Trophoblast differentiation associated genes Tpbpa and Pl1 are not 
primed for transcriptional activation in TS cells. (A) Relative enrichment for 
H3K27me3 and H3K4me2 at Tpbpa and Pl1, loci was assessed by ChIP in ES (green bars) 
and TS (orange bars) cells. TS associated Cdx2 and Fgfr2 are shown here for comparison 
while Actin and Inter. act as controls. (B) RNAP II occupancy was assessed by ChIP using 
4H8-Ser5P and 8WG16 antibodies. TS associated loci Cdx2 and Fgfr2 are again shown here 
for comparison while Actin and Hprt act as controls. Background levels (from control IgG 
antibodies) are shown as grey bars. Data shown is representative of 2 experiments, error 
bars represent s.d. 
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In conclusion Tbpba and Pl1 do not adopt a poised chromatin conformation in TS 
cells. Like many tissue specific genes these loci are controlled by CpG poor promoters and 
as such are less likely to be marked by bivalent chromatin domains, as demonstrated in ES 
cells. Many trophoblast related loci with CpG rich promoters, selected as possible 
candidates for this analysis, were found to be expressed at steady levels in TS cells and 
simply up-regulated upon differentiation. These findings suggest that genes required upon 
trophoblast differentiation are subject to different modes of regulation in ES and TS cells.     
3.6 Conclusion 
In summary, I have investigated the epigenetic regulation of key developmental 
genes in the early mouse embryo using blastocyst -derived stem cells. Bivalent chromatin 
domains, recently identified in ES cells, are thought to provide pluripotent cells with the 
flexibility to differentiate into all three germ layers while preventing premature 
pluripotency loss. Surprisingly, I found that lineage-inappropriate genes can be occupied 
by opposing histone modifications in extra-embryonic committed TS cells. Moreover, high 
levels of H3K4 methylation were retained at these loci upon TS cell differentiation, 
indicating that in the trophoblast lineage loss of developmental potency is not necessarily 
accompanied by loss of this histone modification. Interestingly further examination of the 
chromatin environment at these loci in ES and TS cells revealed a loss of Ring1B or RNAP II 
binding in extra-embryonic cells consistent with loss of gene priming. This opens up the 
fascinating question of how PRC1 recruitment and poised RNAP II occupancy are 
controlled during development.  To understand how different chromatin environments are 
established at bivalent genes in ES and TS cells, I next embarked on a series of experiments 
using a previously established system in which ES cells can be induced to acquire a TS cell 
fate. 
Page | 75 
 
  
Page | 76 
 
Chapter 4 – Results  
Dynamic chromatin changes at bivalent genes upon Oct4 shutdown in ES cells 
and acquisition of a TS-like phenotype.   
 For many years Oct4 has been regarded as a key regulator of lineage choice in the 
early embryo. Oct4 is a POU domain containing transcription factor expressed in all 
blastomeres and becomes restricted to the ICM at the late blastocyst stage due to 
repression in the TE, where Cdx2 is highly expressed. In Oct4 null mice ICM formation 
occurs but cannot be maintained and cells inside the blastocyst instead divert towards TE 
(Nichols et al., 1998). ES cells express high levels of Oct4 and when injected into developing 
embryos will contribute almost exclusively to embryonic tissues. Due to this evident 
contribution bias many stem cell biologists concluded that ES cells were unable to 
differentiate into extra-embryonic trophectoderm. However, recent studies have shown 
that, subject to manipulation, ES cells are indeed able to differentiate and give rise to extra-
embryonic trophoblast cells both in vitro and in vivo (Lu et al., 2008; Niwa et al., 2000; 
Niwa et al., 2005; Schenke-Layland et al., 2007). This advance in our understanding was 
first made using an ES cell line denoted ZHBTc4 in which Oct4 expression is subject to 
conditional inactivation (Niwa et al., 2000). This ES cell differentiation system has been 
used in the following experiments to explore the intricate relationship between Oct4, the 
epigenetic regulation of key developmental genes and embryonic versus extra-embryonic 
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4.1 ZHBTc4-ES cell characterisation and TS-like cell derivation in vitro. 
 Over recent years Histoshi Niwa and colleagues have explored the relationship 
between Oct4, Cdx2 and lineage identity by genetically manipulating blastocyst -derived 
stem cells.  A tet transactivator and Doxycycline (Dox) controlled Oct4 transgene were first 
inserted into an E14Tg2a ES cell line. Endogenous Oct4 alleles were subsequently 
disrupted by insertion of internal ribosome entry sites (IRES) (ZHBTc4 ES cells; 
Figure.4.1A). The following experiments were undertaken to verify the system developed 
by H. Niwa. 
Immunofluorescence analysis was conducted to assess the speed and uniformity of 
Doxycycline (Dox) response across ZHBTc4 ES cells. After twenty four hours of Dox 
treatment a complete loss of Oct4 protein is seen in all cells (Figure 4.1B and Table IV). In 
response, Cdx2 positive cells steadily increase in number throughout the course of 
treatment reaching 40% of the population by 72 hours. ES cell associated proteins Nanog 
and Sox2 persist in a high proportion of cells at 24 hours but this gradually decreases over 
time (Table IV). Expression analysis showed that following Oct4 shutdown repressed 
targets such as H19 are up-regulated, while genes that are normally activated by Oct4 such 
as Utf1 decreased. ES associated markers Sox2, Nanog and Fgf4 are also Oct4 targets. These 
genes show a more gradual pattern of gene repression (Figure 4.1C). Trophectoderm 
markers (Cdx2, Fgfr2, and Hand1) are all up-regulated in response to Oct4 depletion. 
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Figure 4.1.  ZHBTc4 ES cell system characterisation. Methodology employed by Hitoshi 
Niwa and colleagues to construct ZHBTc4 using E14Tg2A ES cells (A). Speed and 
uniformity of Doxcycline (Dox) response was assessed by immunofluorescence staining for 
Oct4 and TE associated Cdx2 before and after 24 hours of Dox treatment (ESDox). Scale bars 
represent 10µm. (B) mRNA levels of Oct4 and known targets (Utf1 and H19), ES and TS 
associated transcripts were measured by qRT-PCR after 24 and 48 hours of Dox treatment. 
Expression levels are shown relative to untreated ZHBTc4 cells.  (C)  
Abbreviations: SA - splicing acceptor site, IRES - internal ribosome entry site, hph - 
hygromycin phosphotransferase, CAG – cytosine adenine guanine, tTA - tetracycline 
controlled transactivator, pA - simian virus polyadenylation signal, hCMV*1 - human 
cytomegalovirus promoter ligated to a tet operator, b-geo  - LacZ-neomycin resistance 
fusion gene, Zeo – zeocin, BSD – blasticidin S deaminase. 
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    Time after Dox induction (hours)   
  
 
0 24 48   
  Oct4 95 0 0   
  Nanog 82 69 43   
  Sox2 82 72 27   
  Cdx2 2 21 24   
            
 
Table IV. Percentage of positively stained nuclei detected by immunofluorescence 
analysis upon Dox treatment of ZHBTc4 ES cells. Antibodies against Oct4, Nanog, Sox2 
and Cdx2 were used to monitor the percentage of cells expressing lineage-specific 
transcription factors during the course of Dox treatment; results represent the average of 2 
experiments.    
 
To address the relationship between Oct4, lineage identity and chromatin profiles, 
ZHBTc4 ES cells were induced to differentiate into TS-like cells, using an established 
protocol (Niwa et al., 2000). Briefly, ES cells were plated at low density on mouse 
embryonic fibroblasts and induced to repress Oct4 in conditions permissive for TS cell 
derivation (high levels of Fgf4 37ng/ml). Over time the morphology of treated cells altered 
from ES colonies to those with a flattened center thereby creating concave shaped colonies 
(Figure 4.2C). By day 19, cultures showed a more uniform morphology, similar to that of 
‘true’ TS cell line (B1) (Figure 4.2B & C). At this stage, positive staining for trophectoderm 
stem cell marker Cdx2 was seen in the same proportion of ZHBTc4 -derived TS-like cells as 
a wild type TS cell line (85-90%), while Oct4 was undetectable in either culture (Figure 
4.2D). TS-like cells could be serially passaged and were propagated in culture for 6 weeks. 
Together this data proved ZHBTc4 to be a reliable ES cell system in which to conduct my 
experiments.  
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Figure 4.2 TS-like cell derivation from ZHBTc4 ES cells upon Oct4 repression and 
provision of TS cell culture conditions.(A) Schematic of TS-like cell derivation from 
ZHBTc4 ES cells. (B) ZHBTc4 ES cells cultured in TS cell derivation conditions and Dox 
treatment can adopt TS-like (TSL) cell morphology, traditionally derived TS-B1 cells are 
shown here for comparison. (C) During the process of TS-like cell derivation cultures adopt 
a more uniform appearance over time. (D) Immunofluoresence analysis for Cdx2 shows 
comparable staining patterns between TSL cells and traditionally-derived TS-B1 cells. 
(Scale bar represents 10 µm) 
 
4.2 The poised state of bivalent genes alters upon loss of pluripotency and 
Trophectoderm lineage commitment.  
To assess the impact of Oct4 depletion and extra-embryonic lineage acquisition on 
the chromatin environment of key developmental regulators, chromatin was isolated from; 
ZHBTc4 ES cells grown in normal conditions (ES), after 48 hours of Dox treatment (ESDox) 
and after differentiation towards TS-like cells (TSL). Levels of H3K4me2 and H3K27me3 
were assessed at the same panel of candidate loci analysed in the previous chapter. 
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Expression levels of selected genes were also monitored following 24 and 48 hours of 
doxycycline treatment in ES conditions and after TSL derivation, TS cells are also shown 
here for comparison. 
Following Oct4 shutdown early target gene Fgfr2 showed a notable decrease in 
repressive H3K27me3 enrichment levels (ESDox;Figure 4.3). However, other induced loci 
Cdx2, Hand1 and Pax3 (as shown in Figure 4.4) do not show the same dramatic loss. This 
may reflect the previously observed heterogeneity of ZHBTc4 ES cell cultures at this stage 
of Dox treatment (Figure 4.1 and Table IV). In contrast, the pattern of enrichment has 
resolved in TS-like cells, where active promoters; Cdx2, Fgfr2, Hand1, Flk1 and Pax3 show 
low levels of H3K27me3 (p < 0.001; ANOVA), while H3K4me2 remains prominent at these 
loci (p > 0.1; ANOVA). Un-induced genes Math1, Sox1, Hoxa7, Mixl1, Gata4 and Sox7 (as 
shown in Figure 4.4) retain H3K27me3 in ESDox cells and TSL populations when compare to 
untreated ES cells (p > 0.1; ANOVA) (Figure 4.3). Despite the silent transcriptional status of 
these genes, H3K4me2 enrichment is sustained after both Oct4 shutdown and extra-
embryonic cell commitment (p > 0.1; ANOVA). These results suggest that Oct4 depletion 
either directly or indirectly induces bivalent domain resolution at activated loci while un-
induced genes retain both H3K27me3 and H3K4me2 even after differentiation. 
Importantly the epigenetic and transcription profile of TS-like cells was shown to closely 
resemble that of traditionally-derived TS cells.   






Figure 4.3 Bivalent chromatin domains are maintained at un-induced loci in ES cells upon Oct4 shutdown and 
subsequent TS-like cell derivation. Abundance of H3K27me3 and H3K4me2 relative to detected H3 were compared at a 
panel of key developmental genes using ChIP and qPCR in untreated (ES), Dox-treated (48 hours) ZHBTc4-ES (ESDox), TS-
like cells (TSL) and traditionally-derived TS B1 (TS) cells. Background levels (from control IgG antibodies) are shown as 
grey bars. Data shown is from 3 experiments, error bars represent s.d. Brackets demarcate silent developmental genes that 
retain bivalent chromatin domains in TS cells. 





Figure 4.4 Kinetics of candidate gene expression in ZHBTc4-ES cells following Oct4 shutdown and 
trophectoderm lineage commitment. 
Expression levels of selected genes were assessed by qRT-PCR in ZHBTc4-ES cells after 0 (white), 24 (light grey) 
and 48 hours (dark grey) of doxycyline (Dox) treatment to induce Oct4 repression, in ZHBTc4-derived TS-like cells 
(light black) and B1-TS (black) cells. Data was normalised to housekeeping genes (Actin and L19) and expressed 
relative to untreated ZHBTc4-ES cells (ES=1). Data shown represents the mean from 3 experiments, error bars 
represent s.d. 
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Oct4 binding and polycomb targets have been mapped in ES cells by separate 
genome-wide studies, interestingly the two data sets revealed a high degree of overlap 
(Lee et al., 2006; Sharov et al., 2008). Similarities in the expression profiles of ES cells after 
Oct4 shutdown and ES cells deficient in Ring1A and Ring1B were also noted (Endoh et al., 
2008). Furthermore the ZHBTc4 ES cell system was used to demonstrate rapid and global 
loss of PRC1 and PRC2 binding upon Oct4 shutdown, authors concluded that direct 
interaction between Oct4 and Ring1B mediates local engagement of PRC1 and PRC2 in ES 
cells (Endoh et al., 2008).   
To monitor the epigenetic events occurring at key developmental genes upon ES to 
TS cell differentiation I examined the direct impact of Oct4 depletion (ESDox) on Suz12-
PRC2 and Ring1B-PRC1 binding by ChIP and compared enrichment levels to those in 
untreated ES and extra-embryonic lineage committed cells (TS) (Figure.4.5). Consistent 
with data from Endoh et al., genes up-regulated in the ESDox population showed lower 
levels of Suz12 and Ring1B than ES cells, demonstrating a consistent inverse correlation 
between active transcription and polycomb targeting. Interestingly the observed pattern of 
Suz12 in ESDox discriminates more clearly between active and inactive genes than the 
previously observed levels of H3K27me3 in the population, indicating that this mark may 
become lost passively through cell division. In contrast to expressed genes un-induced loci 
such as Sox1, Math1 and Hoxa7 retain both Suz12 and Ring1B enrichment in ESDox 
indicating that PRC1 targeting is not entirely dependent on Oct4 in ES cells. Upon TE 
lineage commitment (TSL) Suz12 targeted genes previously shown to be marked by 
H3K27me3 in this cell type (Math1, Sox1, Hoxa7, Mixl1, Gata4 and Sox7). Intriguingly in TS-
like cells Ring1B detection was comparable to background signals at all candidate genes as 
monitored by anti-IgG in TS-like cells, recapitulating the situation in conventionally-
derived TS cells (Figure.4.5). 






Figure 4.5 Dynamic changes in PRC2 and PRC1 occupancy occur upon Oct4 shutdown and subsequent TS-like cell 
derivation. Binding patterns of PRC2 (Suz12) and PRC1 (Ring1B) were compared using ChIP and qPCR in untreated (ES), 
Dox-treated (48 hours) ZHBTc4-ES (ESDox), TS-like cells (TSL) and traditionally-derived TS B1 (TS) cells. Background levels 
(from control IgG antibodies) are shown as grey bars. Data shown is representative of 3 experiments, error bars represent 
s.d. Brackets demarcate silent developmental genes that retain bivalent chromatin domains in TS cells. 
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 Ring1B and poised RNAP II have been shown to co-localise at key developmental 
genes marked by bivalent chromatin domains in ES cells. To further examine the 
relationship between PCR1 and RNAP II, I examined its recruitment and conformation of 
during the process of Oct4 shutdown and TS-like cell derivation when Ring1B becomes 
depleted. ChIP was carried out using antibodies against either Ser5-phosphorylated or 
hypo-phosphorylated (8WG16) (Ser5P; 4H8) RNAP II. As shown in Figure 4.5, bivalent 
genes and the active control (Actin) were found highly enriched for Ser5P RNAP II at their 
promoter regions in ES cells. Poised RNAP II conformation was discriminated by low levels 
of 8WG16 binding. The pattern of enrichment in the ESDox population is less clear, activated 
genes (Cdx2, Fgfr2, Hand1 and Pax3) seem to lose Ser5P RNAP II binding, suggesting that it 
is necessary to remove poised RNAP II before a normal cycle of transcription can occur. As 
noted earlier Fgfr2 is an early response Oct4 target, consistent with this interpretation, 
increased levels of 8WG16 are observed at this locus. Interestingly Ser5P enrichment is 
still evident at un-induced Math1, Sox1 and Hoxa7 in ESDox cells as previously seen for 
PRC1, indicating that Oct4 alone is not responsible for keeping genes poised for future 
expression in ES cells. Active genes in TSL cells (Cdx2, Fgfr2, Hand1, Flk1 and Pax3) showed 
enrichment for both RNAP II complexes. While like PRC1, little RNAP II enrichment was 
detected at the promoters of Math1, Sox1, Hoxa7, Mixl1, Gata4 and Sox7 in TS-like cells. 




Figure 4.6 Transcriptional gene priming of embryonic developmental regulators is lost upon Trophectoderm 
lineage commitment. Abundance of Ser5P RNAP II and 8WG16 RNAP II complexes were compared using ChIP and 
qPCR in untreated (ES), Dox-treated (48 hours) ZHBTc4-ES (ESDox), TS-like cells (TSL) and traditionally -derived TS B1 
(TS) cells. Background levels (from control IgG antibodies) are shown as grey bars. Data shown is from 3 experiments, 
error bars represent s.d. Brackets demarcate silent developmental genes that retain bivalent chromatin domains in TS 
cells. 
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 Differential regulation of key developmental genes in ES and TS cells was 
previously demonstrated. Although bivalent domains were observed in the two cell types, 
PRC1 and poised RNAP II were notably absent from lineage-inappropriate genes in extra-
embryonic restricted cells, indicative of a loss of gene priming. Using ZHBTc4 ES cells I 
have shown that such distinctions are dependent on lineage identity. Differentiation of ES 
cells to TS-like cells induced chromatin remodeling at previously poised loci to mimic the 
situation in traditionally -derived TS cells. Interestingly when I examined the direct impact 
of Oct4 depletion (ESDox) I found that PRC1 and poised RNAP II were maintained at some 
key developmental genes, suggesting that gene priming in ES cells is not solely dependent 
on the gatekeeper of pluripotency. 
4.3 Developmentally-regulated changes in the gene expression profiles of 
chromatin modifying complexes  
 Dominant transcriptional regulators Oct4 and Cdx2 play key roles in specifying 
embryonic and extra-embryonic lineage identity; as a consequence gene expression 
patterns undergo significant changes upon ES differentiation towards TS-like cells. This 
process is likely to modify the cellular composition of epigenetic regulators, which may 
facilitate the previously observed chromatin remodeling at key developmental genes. I 
assessed mRNA levels of a range of chromatin modifiers (see full list of genes analysed in 
Figure 4.7A) in ES cells, ESDox populations, TS-like cells and traditionally -derived TS cells.  
 A summary of expression analysis is shown in Figure 4.7 and raw data is provided 
in Appendix III.  Untreated ES cells are used as a reference, down-regulated genes are 
indicated in blue and red illustrates a greater than two fold (+/- s.d.) increase. Initial 
comparison of ES and TS cells highlighted clear differences between the two 
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developmentally distinct stem cells types. TS-like cells showed a remarkably similar profile 
to traditionally -derived TS with only a two exceptions (LSD1 and MLBR). Early changes in 
chromatin modifier composition induced directly by Oct4 shutdown are reflected by Dox 
treated ZHBTc4 cells (ESDox) those differences associated with extra-embryonic lineage 
restriction are represented by TSL and TS cells, expressions level were normalised to 
untreated ES cells.  
 In agreement with previous reports (Mak et al., 2004; Matoba et al., 2006), Eed 
expression was significantly reduced, in contrast to its partners, Ezh2 and Suz12, in TS and 
TSL cells as compared to ES cells. In mammalian cells the PRC1 complex has a large 
number of potential subunits and is therefore likely to exist in various forms (Otte and 
Kwaks, 2003). Some PRC1 subunits such as chromodomain containing protein-Cbx8 and 
polyhomeotic gene-Phc2 were up-regulated upon differentiation while others such as Phc1 
and Ring1a were repressed.  Interestingly differential recruitment of Phc1 and Phc2 on the 
inactive X chromosome has been previously documented in ES and TS cells, respectively 
(de Napoles et al., 2004). In contrast, fewer changes occur among the Mixed lineage 
leukemia (MLL) family of proteins that mediate H3K4 methylation, yet MLL3 was down-
regulated in TS and TSL cells. H3K4 demethylase LSD1, the first demethylase to be 
identified, show reduced expression levels in TS cells however, this trend was not observed 
upon Oct4 shutdown or TSL cell derivation. A large number of Jumonji C (JmjC) domain 
containing proteins have recently been shown to function as histone demethylases (Cloos 
et al., 2008). The expression levels of two such demethylases, which target H3K27me3 
showed disparate expression patterns, UTX is maintained while Jmjd3 increases during 
treatment and TE lineage commitment, suggestive of an involvement in remodeling 
chromatin at activated genes. DNA methylation (by addition of a methyl group to the 
position 5 carbon of cytosine) also plays a major role in epigenetic regulation of gene 
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transcription. DNA methyl transferase maintenance enzyme Dnmt1 and de novo methyl 
transferase Dnmt3b expression were maintained upon Oct4 shutdown. While Dnmt3a and 
methyltransferase co-factor-Dnmtl showed a lower level of expression in TS and TSL cells 
compared to ES.  
 Surprisingly, a pronounced imbalance in mRNA levels for several H3K9 methylases 
(Ehmt1, G9a, Suv39h1 and Suv39h2) and H3K9 demethylases (Jmjd1a and Jmjd2c) was 
observed between ES and TS cells. In particular, Suv39h1 H3K9 tri-methyltransferase was 
rapidly up-regulated upon Oct4 shutdown in Dox-treated ES cells and remained highly 
expressed throughout TSL cell derivation. Conversely, recently identified H3K9 
demethylases (Jarid1c, Jmjd1a and Jmjd2c) are highly expressed in ES cells and steadily 
down-regulated upon Dox treatment (Cloos et al., 2006; Loh et al., 2007; Wissmann et al., 
2007). Further experiments were carried out to examine whether this dramatic change in 
the ratio of H3K9 demethylases to methylases may impact on the epigenetic regulation of 














Figure 4.7 Expression profiles of selected chromatin modifying complexes upon Oct4 
repression and TS-like cell derivation. (A) The expression of selected chromatin 
modifying complexes was compared using qRT-PCR in ZHBTc4-ES and B1-TS cells (left 
panel); ZHBTc4 after 24 and 48 hours of Dox treatment (ESDox) and in ZHBTc4 -derived TSL 
cells (right column). Values shown are normalised to Actin and L19 and are relative to 
untreated ES cells (ES=1, left panel). Up-regulation (mean +/- s.d. >2) and down-regulation 
(mean +/- s.d. <0.5) are coloured in red and blue, respectively.  (B) Histograms showing 
the expression pattern of Cdx2, Oct4, Suv39h1, Jmjd2c, Suz12 and Ring1B upon Oct4 




Page | 92 
 
4.4 Suv39h1 targets lineage-inappropriate bivalent genes in TS-like and TS 
cells. 
Upon TE lineage commitment key developmental genes become depleted in PRC1- 
Ring1B binding and no longer assemble poised RNAP II. I have observed a concomitant 
increase in H3K9 methyltransferase Suv39h1 mRNA levels. Ring1B and Suv39h1 have been 
shown to bind in a mutually exclusive fashion in the zygote. Ring1B is targeted to paternal 
heterochromatin which is devoid of H3K9me3 and HP1  while maternal heterochromatin 
is bound by Suv39h1. Artificially depletion of H3K9me3 and Suv39h1 causes Ring1B to 
bind and act as a repressor on both paternal and maternal heterochromatin illustrating a 
dominant role for Suv39h1 in blocking Ring1B targeting (Puschendorf et al., 2008).  
To address whether bivalent genes could be directly targeted by Suv39h upon TE 
lineage commitment in the absence of PRC1 binding, we compared the abundance of 
H3K9me3 histone marks and Suv39h1 occupancy at a panel of developmental regulators 
and control (Actin and -satellite) loci in ES, Dox-treated ES (ESDox48h), TSL and TS cells 
(Figure 4.8). As anticipated, genes that are activated upon Oct4 shutdown and TSL cell 
derivation and retain high levels of H3K4me2 while losing both H3K27me3 and Suz12 
binding (Cdx2, Fgfr2, Hand1, Flk1 and Pax3) showed little enrichment for H3K9me3 (Figure 
4.8A and Appendix IV). In contrast, H3K9me3 was acquired at genes that remain inactive 
and marked by bivalent chromatin domains (Math1, Sox1, Hoxa7, Mixl1, Gata4 and Sox7) 
through Suv39h1 recruitment (Figure 4.8B). 
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Figure 4.8 Suv39h1 mediated H3K9me3 occupies lineage-inappropriate genes upon Trophectoderm lineage cell 
commitment. The patterns of H3K9me3 (A)  and Suv39h1 occupancy (B) at bivalent promoters in ZHBTc4-ES cells after 0 (green; 
ES) and 48 hours (light-green; ESDox) of Doxycycline treatment to induce Oct4 repression, ZHBTc4 -derived TS-like cells (light 
orange; TSL) and B1-TS cells (orange; TS). Data shown is average of 3 experiments, error bars represent s.d. Brackets demarcate 
silent developmental genes that retain bivalent chromatin domains in TS cells. 
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 Interestingly, little H3K9me3 was acquired in ESDox4 cells where Ring1B and Ser5P 
RNAP II forms were transiently retained at un-induced loci, in contrast to TSL cells, 
indicating that the appearance of H3K9me3 and loss of poised chromatin features are 
likely to be coordinated (Appendix IV). High levels of H3K9me3 were also observed at 
constitutive heterochromatin ( -satellite repeats) while actively transcribed Actin showed 
little enrichment throughout the four cell populations. 
Suv39h1 mediated H3K9me3 is associated with gene silencing and commonly 
interacts with HP1 at constitutive heterochromatin. Together Suv39h1 and HP1 have been 
shown to repress transcription by stabilising heterochromatic subdomains. Chromatin 
structures such these enable DNMTs to distinguish transcriptionally repressed states from 
active loci, as these enzymes have little intrinsic target specificity of beyond CpG 
dinucleotides (Fujita et al., 2003; Fuks et al., 2003a). To explore whether key 
developmental genes marked by H3K9me3 in TS cells are subjected to further layers of 
repression, DNA methylation levels of Math1, Sox1, Hoxa7, Mixl1, Gata4 and Sox7 were 
monitored by methylated DNA immunoprecipitation (MeDIP) analysis (in which a 5’ 
methylcytosine antibody is used to precipitate methylated DNA from genomic DNA).   





Figure 4.9 DNA methylation consolidates Suv39h1-mediated H3K9me3 at bivalent genes upon trophectoderm lineage 
commitment. The abundance of 5-methyl cytosine was assessed by MeDIP at selected promoters in; ZHBTc4-ES cells after 0 (green; 
ES) and 48 hours (light-green; ESDox) of Doxycyline treatment to induce Oct4 repression, ZHBTc4 -derived TS-like cells (light orange; 
TSL) and B1-TS cells (orange; TS). Data shown is average of 3 experiments, error bars represent s.d. Immuno-preciptations were 
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As anticipated, minimal DNA methylation levels were detected at poised genes in ES 
cells. Dox treated ES cells in which Oct4 had been depleted for 48 hours (ESDox) showed no 
signs of DNA methylation other than at satellites ( sats , which function here as a 
positive control. In TS and TSL populations expressed genes Cdx2, Fgfr2, Hand1, Flk1 and 
Pax3 show similar levels to actively transcribed control locus (Actin). However, genes 
targeted by Suv39h1 mediated H3K9me3 (highlighted) were shown to be further silenced 
by de novo DNA methylation in TSL and TS cells with enrichment detected at, Sox1, Hoxa7, 
Mixl1, Gata4 and Sox7  (Figure. 4.9).  These results strongly suggest that Suv39h-mediated 
H3K9me3 and associated DNA methylation cooperate to stably ‘lock-in’ bivalent a silent 
state at lineage-inappropriate genes upon loss of PRC1 during trophoblast lineage 
commitment. These findings contrast with prevailing views that loss of H3K4 methylation 
is a prerequisite for poised chromatin resolution (Bernstein et al., 2006a; Meissner et al., 
2008; Mohn et al., 2008). The presence of a trivalent chromatin domain (H3K4me2, 
H3K27me3 and H3K9me3) was confirmed by a series of sequential ChIP experiments by A. 
Helness (Appendix V). Recent genome-wide studies have highlighted that bivalent 
developmental regulators in ES cells are more likely than univalent high CpG promoters to 
become targeted by DNA methylation, demonstrating on a more global scale that these key 
developmental loci are targeted by multiple levels of silencing in different cell types 
(Meissner et al., 2008).   
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4.5 Conclusion 
 In summary, I have shown that that PRC1 (Ring1B) and poised RNAP II – two 
hallmarks of gene priming in pluripotent cells, are dynamically removed from the 
promoters of bivalent genes upon TE cell fate acquisition. This coincides with the addition 
of the key repressive marks, H3K9me3 alongside DNA methylation at promoters that 
retain high levels of methylated H3K4. This results in a trivalent (H3K9me3-H3K27me3-
H3K4me2) histone conformation induced by Suv39h1 occupancy at silent, lineage-
inappropriate genes in TS and TS-like cells. Additional layers of repression may provide a 
fail-safe mechanism to ensure transcription of key developmental genes occur within the 
appropriate cell type at the correct stage of development. The alternative method of 
resolving poised chromatin outlined here implies that pluripotency is safeguarded within 
the early embryo by active protection from H3K9 methylation and accompanying de novo 
DNA methylation. The biological significance of bivalent chromatin domain formation and 
resolution during development is yet to be established in vivo. The following experiments 
examine the epigenetic status of developmental genes in the ICM and TE, isolated directly 
from early blastocysts. 
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Chapter 5 – Results 
 
In vivo analysis of bivalent chromatin marks and epigenetic differences at key 
developmental genes in the early mouse embryo.  
 Epigenetic analysis of the early mouse embryo has until very recently been limited 
to monitoring global levels of methylated DNA and modified histones by 
immunofluorescence. Using this technique epigenetic asymmetries between ICM and TE 
were revealed,  higher levels of DNA methylation were seen in ICM cells compared to 
surrounding TE cells (Santos et al., 2002).  A more detailed analysis of these distinct cell 
types has since been possible due to the derivation of ES and TS cells and the recent 
development of MeDIP. Intriguingly it was shown that the higher levels of DNA 
methylation previously detected by immunofluorescence in the ICM largely reflects 
intergenic and non-promoter regions as lower enrichment of 5’mC was globally detected at 
promoters in ES cells than TS cells (Farthing et al., 2008).  
 Locus specific epigenetic analysis of the early embryo has until recently been 
restricted to in vitro cultured blastocyst -derived stem cells as ChIP analysis typically 
requires millions of cells as starting material. In the last few years efforts have been made 
to modify existing ChIP protocols to enable the analysis of smaller cell populations 
(Acevedo et al., 2007; Dahl and Collas, 2008; O'Neill et al., 2006). Carrier-ChIP, previously 
developed by Laura O’Neill and Matthew VerMilyea, works on the principal that millions of 
evolutionary distant carrier cells can be used to protect precious cell samples from critical 
losses during chromatin preparation and immunoprecipitation. C-ChIP was first described 
in 2006 where authors compared the epigenetic profiles of a limited number of loci 
including Oct4 and Cdx2 in dissected embryo samples ICM and TE samples (approximately 
100 cells). In this analysis I used C-ChIP to explore the existence, formation and resolution 
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of bivalent chromatin domains at key developmental loci in vivo prior to and after lineage 
segregation in the early blastocyst.   
5.1 Epigenetic characterisation of the early embryo using Carrier ChIP 
 Embryos were collected from oviducts of superovulated prepubescent CBAB6 F1 
females 2 days after mating with CBAB6 F1 males. Morula stage embryos were cultured 
overnight before morphology based selection of early blastocyst stage embryos the 
following day. ICM samples were isolated by immunosurgery, a technique first established 
in 1975 (Solter and Knowles, 1975). Mouse antibodies are unable to penetrate through the 
trophoblastic layer of a blastocyst, therefore when immunoglobulin coated embryos are 
transferred to guinea pig complement, selective lysis of the TE begins releasing pure 
unaffected ICM. As shown in Figure 5.1A pure TE samples were harvested mechanically, 
blastocysts were immobilised using a fine holding pipette and micro manipulator 
apparatus allowing the physical separation of mural TE using a micro-dissection blade. 
Compacted morula stage embryos were simply collected at 2.5 d.p.c and snap frozen. The 
C-ChIP method, outlined in Figure 5.1B, requires mixing Drosophila S2 cells and embryo 
samples before preparation of nuclei and chromatin. Native chromatin fragments were 
prepared by micrococcal nuclease digestion before immunoprecipitation with antisera to 
modified histones, nonspecific precipitation was monitored by preimmune IgG. 
 




Figure 5.1. Dissection of Inner Cell Mass and Trophectoderm from early blastocysts 
and schematic of Carrier-ChIP protocol. Typical early blastocyst selected for 
experiments described below (A). ICM samples were prepared by immmunosurgery; 
complement-induced lysis of trophoblast cells allows collection of relatively pure ICM 
preparation (top). Mural trophectoderm was separated by manual dissection. Blastocysts 
were retained by a holding pipette and the mural trophectoderm cut away from ICM and 
collected for C-ChIP analysis (bottom). (B) A diagrammatic summary of the C-ChIP 
protocol. 
 
 The C-ChIP protocol used in this study was tailored to accomplish adequate 
detection by qPCR, replacing previously used PCR incorporating [ 32P] dCTP. Species 
specific primers were designed and monitored for amplification efficiency in demanding, 
low template conditions (Figure 5.2). 




Figure 5.2. Efficient, species-specific primers are required for C-ChIP analysis using quantitative PCR amplification 
(A)C-ChIP samples commonly reach cycle threshold (dotted line) above 30 cycles. Efficiency plots illustrate primer 
performance across serial dilutions of mouse DNA in this low template range. (B) Amplification plots in log scale illustrate 
detected fluorescence against number of cycles in PCR reactions containing mouse DNA only (M), C-ChIP samples (eg. 12 ICM 
or TE samples) (IP) or Drosophila DNA only (D). (C) Melting curves demonstrate primer specificity, amplicons from mouse 
only DNA and C-ChIP samples are consistent while Drosophila DNA only wells are distinct.   
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Chromatin was typically prepared from approximately 400 cells increasing the 
quantity of mouse embryo samples four-fold compared to the established C-ChIP method. 
This modified approach was initially validated using a previously characterised H4K16ac 
antibody and H3K4me2 to monitor modified histone levels at Oct4 and Cdx2 loci (O'Neill et 
al., 2006). Consistent with previously described data, higher levels of H4K16ac were 
detected at Oct4 in the ICM than the TE while Cdx2 showed higher levels in the TE in which 
it is highly expressed. As shown in Figure 5.3 levels of H3K4me2 enrichment were 
consistent with H4K16ac, with lower amounts of H3K4me2 detected at Oct4 in the TE than 




Figure 5.3 Validation of modified Carrier ChIP protocol. C-ChIP and qPCR were used to 
assess levels of H4K16ac and H3K4me2 at Oct4 and Cdx2 loci in ICM (green) and TE 
(orange).  Unspecific precipitation is monitored by pre-immune IgG control showing only 
background levels as expected. Antibody-bound and unbound chromatin fractions were 
amplified in parallel by qPCR using the same quantity of DNA; enrichments are expressed 
as bound/unbound ratios. Error bars represent s.d for two (H4K16ac) and three 
(H3K4me2 and IgG) independent experiment using triplicate PCR amplifications for each 
gene.     
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5.2  H3K9me3 is acquired at bivalent loci in the TE upon blastocyst lineage 
segregation.  
 To explore the biological significance of bivalent chromatin domains, previously 
only observed in vitro, I used C-ChIP to analyse the epigenetic profiles of Oct4, Cdx2, Sox1, 
Gata4 and Mixl1 after blastocyst formation (ICM and TE) and earlier in development 
(compacted morula). The transcriptional status of candidate genes was first verified by 
purification of mRNA from dissected ICM or TE and compacted morula.  Consistent with 
previous reports Oct4 and Cdx2 were co-detected in the morula (Figure 5.4). Cdx2 mRNA 
levels were high in the TE while Oct4 remains detectable in both ICM and TE at the early 
blastocyst stage as previously reported. In contrast, Sox1, Gata4 and Mixl1 were not 
detected at any developmental stage tested in this analysis. 
 
 
Figure 5.4 Expression levels of candidate loci before and after blastocyst lineage 
segregation. Expression levels of candidate genes, as assessed during one typical series of 
dissections, mRNA was extracted from compacted morula (grey), isolated ICM (green) and 
TE (orange) and qRT-PCR was conducted. Values shown are normalised to S17 and L19.  
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 Levels of H3K4me2 and H3K27me3 were examined to determine if bivalent 
chromatin domains mark key developmental genes in vivo. Enrichment for H3K9me3 was 
also assessed, to determine whether alternative repressive pathways act in the ICM and TE, 
as observed in stem cells, and explore the time at which such differences are established 
during development. Typically, chromatin was prepared from 10-12 ICM or TE samples or 
20 compacted morulae combined with 5x106 Drosophila S2 cells per immunoprecipitation. 
Input chromatin was incubated with H3K4me2, H3K27me3, H3K9me3 or an unspecific 
control IgG. Precipitated DNA sequences constituted the bound fraction and the 
corresponding supernatant formed the unbound fraction. DNA was quantified by 
picogreen fluorometry and unbound fractions diluted to match that of bound samples, 
before PCR analysis. Results are displayed as a ratio of bound to unbound values 
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Figure 5.5. Distinct repressive pathways regulate key developmental genes in the 
ICM and TE of the early blastocyst. Carrier ChIP and qPCR were used to assess levels of 
H3K4me2, H3K27me3 and H3K9me3 at the promoters of Oct4, Cdx2, Sox1, Gata4 and Mixl1 
in compacted morulae (grey), ICM (green) and TE (orange). Antibody-bound and unbound 
chromatin fractions were amplified in parallel by qPCR using the same quantity of DNA. 
Enrichments are expressed as bound/unbound ratios. Error bars represent s.d. of 3 
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 As shown in Figure 5.2, H3K4me2 is detected at Oct4 in all three embryo samples, 
in contrast to repressive H3K27me3 and H3K9me3. Oct4 is predominantly expressed in the 
ICM, which shows highest levels of H3K4me2, the TE in which expression is still detected 
also showed significant levels of H3K4me2. Interestingly H3K27me3 and H3K9me3 levels 
are on the brink of detection in TE, which may indicate Oct4 silencing has started to occur 
in a subset of cells within the TE samples, consistent with continuing blastocyst 
maturation. Cdx2 also shows enrichment for H34me2 in all three cell populations with 
highest levels observed in the TE in which the locus is expressed. Within the ICM Cdx2 is 
also marked by H3K27me3 as previously observed in ES cells. Similarly Sox1, Gata4 and 
Mixl1are also marked by both H3K4me2 and H3K27me3 indicating that bivalent chromatin 
domains exist in vivo at early stages of development. The epigenetic status of candidate loci 
were also assessed in 8-cell embryos, yet little difference was observed between this 
earlier stage and compacted morula (Appendix VI). Most interestingly, however, H3K9me3 
is solely detected in the TE demonstrating that alternative repressive pathways operate in 
vivo to regulate key developmental genes in a lineage specific manner.  
5.3 Conclusion 
 Use of C-ChIP has allowed me to demonstrate for the first time that bivalent 
chromatin domains exist in vivo suggesting that these are biologically significant structures 
that function to regulate genes during embryonic development. Such domains are 
associated with gene priming in ES cells and identification of similar signatures in the 
compacted morulae indicates such tight transcriptional control may operate in the embryo 
before ICM formation from which ES cells are -derived. Within the morula it is essential 
that a subset of cells commit to an extra-embryonic fate ensuring embryo implantation and 
future development of the embryo proper. I have shown that cells which undergo TE 
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lineage-restriction acquire H3K9me3 at key developmental genes in contrast to those that 
contribute towards the ICM. H3K9me3 is inherently associated with gene repression and 
as such may consolidate lineage choice by inducing gene silencing at embryonic associated 
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Chapter 6 - Discussion 
 
 In 2006, several studies in ES cells revealed a critical role for polycomb repressors 
in stably maintaining a pluripotent cell identity in vitro (Azuara et al., 2006; Bernstein et al., 
2006a; Boyer et al., 2006b; Lee et al., 2006).  Whether ES cell epigenetic features can also 
be seen in vivo and to what extent PRC-mediated marking is involved in delineating 
pulripotency in the early mouse embryo remained to be established. In this study, I have 
focused on pre-implantation development to evaluate whether bivalent or poised 
chromatin signatures are specific attributes of emerging pluripotent cells. To further our 
understanding of how bivalent chromatin domains are resolved I examined the epigenetic 
status of candidate loci during the process of extra-embryonic lineage commitment. Using 
blastocyst-derived stem cells and ChIP analysis, I have shown that many silent lineage-
inappropriate genes retain bivalent histone signatures in extra-embryonic TS cells. 
However, unlike ES cells Ring1B and poised RNAP II do not occupy these genes in TS cells, 
consistent with loss of gene priming. In order to further understand the intricate 
relationship between lineage identity and dynamic chromatin changes, I exploited the 
potential to convert ES cells into TS-like cells upon conditional Oct4 shutdown (Niwa et al., 
2005). I demonstrated PRC2-bound bivalent, lineage-inappropriate genes become targeted 
by Suv39h1-mediated H3K9me3 and DNA methylation upon extra-embryonic lineage 
commitment and undergo loss of poised RNAP II and Ring1B binding. Collectively, these 
data suggest that Suv39h1 and Ring1B may play a mutually exclusive role in regulating the 
fate of bivalent genes during pre-implantation embryo development.  
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 I further explored the biological significance of bivalent chromatin domains in vivo 
upon lineage segregation in the blastocyst to compare and contrast the pluripotent inner 
cell mass and lineage restricted trophectoderm. I demonstrate for the first time the 
occurrence of bivalent domains in vivo and propose a model illustrated in Figure 6.1 in 




Figure 6.1. Model for the establishment of distinct chromatin states at bivalent genes 
upon blastocyst lineage segregation. The transition from morula to blastocyst marks the 
first lineage segregation event in mammalian development. RNA Polymerase II (RNAP) and 
Ring1B (PRC1) depletion at Suz12 (PRC2)-bound bivalent (H3K4me2 and H3K27me3) loci 
is associated with acquisition of an extra-embryonic fate and addition of Suv39h1-
mediated H3K9me3 and DNA methylation (5mC). 
 
 Importantly the model proposes that transcriptional priming of key developmental 
genes by RNAP II and Ring1B only occurs in pluripotent cells of the early embryo. In 
contrast, Ring1B and poised RNAP II are substituted by Suv39h1-mediated H3K9me3 and 
DNA methylation at bivalent lineage-inappropriate genes in TE-committed cells. The loss of 
Ring1B in TE-derived stem cells may not however, entirely exclude the possible 
recruitment of other PRC1-like complexes at genes marked by bivalent domains, owing to 
the dynamic composition of polycomb complexes during development (Otte and Kwaks, 
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2003).  For example different mPhc homologs Phc1 and Phc2 show reverse gene 
expression patterns in ES and TS cells and consequently are differentially recruited to the 
inactive X chromosome in these two cell types (de Napoles et al., 2004).  
 A key role for Ring1B in regulating developmental potential is consistent with 
previous data both in vitro and in vivo. In ES, cells conditional knockdown of Ring1A/B 
revealed a critical role for PRC1 in stably maintaining a pluripotent state in culture (Stock 
et al., 2007; van der Stoop et al., 2008). While morphologically normal blastocyst form in 
Ring1B mutant mice, embryonic development is becomes severely compromised shortly 
after implantation (Puschendorf et al., 2008; Voncken et al., 2003). The mechanism 
underlying PRC1 targeting at key developmental genes in pluripotent cells as opposed to 
extra-embryonic cells remain unclear. Interestingly the loss of Ring1B binding at bivalent 
genes in TS cells is reflected by a loss of poised RNAP II reiterating the existence of a 
unique mechanistic relationship between these two complexes (Stock et al., 2007). This 
dynamic association is illustrated by the loss of PRC1 at induced genes such as Fgfr2 at 
which the change in RNAP II conformation from poised in ES cells to active in TS cells.   
Depletion of Ring1B and poised RNAP II was also observed at un-induced genes during the 
process of ES differentiation to TS cells, yet the dynamics of this process were distinct.  
Enrichment was transiently retained at bivalent genes in ESDox cells, suggesting that 
chromatin remodeling at these loci (from poised to repressed) may occur more gradually.  
 The permanent silencing of key developmental genes in extra-embryonic TE and 
maintenance of gene priming in ICM must be co-regulated in vivo during blastocyst 
formation and the emergence of these two distinct lineages. One view of how this might be 
achieved is that pluripotency could be safe-guarded in the ICM through active protection 
from H3K9 and DNA methylation. In keeping with this hypothesis a H3K9 demethylase and 
Oct4 target - Jmjd2c is highly expressed in ES cells compared to TS cells and was recently 
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proven to be essential for maintaining pluripotency in culture (Loh et al., 2007).  
Alternatively, recruitment and/or maintenance of poised RNAP II and Ring1B targeting 
exclusively in the ICM could be accomplished by pluripotency associated factors, a 
mechanism that would not function in extra-embryonic tissues.  Oct4 and Nanog appear as 
prime candidates to direct such lineage-specific targeting; both are expressed in all cells of 
the morula stage embryos and become gradually restricted to the ICM and Epiblast. 
However, complete depletion of Oct4 in Dox treated ZHBTc4 ES cells did not cause a rapid 
loss of either Ring1B or poised RNAP II from un-induced loci in these experiments. 
Additional ChIP analysis in our laboratory comparing Nanog expressing and null ES cell 
lines showed similar patterns of poised RNAP II at many candidate genes (F.Lavial and 
O.Alder unpublished data). Together these results indicate that gene priming in ES cells is 
not maintained by Oct4 or Nanog alone; however, this doesn’t not exclude a role for these 
transcription factors in initially targeting PRC1 or poised RNAP II. 
  RNAP II tightly associates with the core promoter recognition complex (TFIID), a 
multiprotein complex known to influence its targeting. Recent studies have revealed that 
TFIID composition alters during differentiation. This is best illustrated by the dramatic 
changes in levels of TATA-box binding protein associated factors (TAFs – subunits of 
TFIID) during myoblast to myotube maturation that ultimately influence RNAP II 
engagement at key developmental genes such as MyoD (Deato et al., 2008; Deato and Tjian, 
2007). It may therefore be of interest to explore TAFs and TFIID complex composition in 
ES and TS cells where differential RNAP II enrichment has been observed. In keeping with 
this hypothesis, microarray data comparing ES and TS cells revealed TAF9 as a potential 
candidate worthy of further investigation (Tanaka et al., 2002). 
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In eukaryotes, Suv39h H3K9 tri-methyltransferases are commonly associated with 
constitutive heterochromatin formation and function. In the zygote paternal constitutive 
heterochromatin lacks Suv39h1 mediated H3K9me3 and is instead targeted by PRC1 
components including Ring1B (Puschendorf et al., 2008). In Suv39h1-deficient zygotes, 
PRC1 associates with maternal heterochromatin lacking H3K9me3, revealing hierarchy a 
between repressive pathways. This differential loading of Ring1B and Suv39h1 onto 
heterochromatin underlies parental genome asymmetry in the zygote and is subsequently 
maintained through cell divisions up to the 8-cell stage (Puschendorf et al., 2008). In this 
study, I showed that Ring1B and Suv39h1 selectively target key developmental genes in a 
lineage specific manner at the blastocyst stage, suggesting that Ring1B/Suv39h1 mutual 
exclusion can occur throughout pre-implantation development.  Efforts within our 
research group have been made to further explore the possible mechanistic relationship 
between Ring1B targeting and Suv39h1 mediated H3K9me3 at bivalent genes upon TE cell 
fate acquisition.  In particular we set out to establish whether over-expressing Suv39h1 in 
ES cells could directly alter the epigenetic status of bivalent loci and induce the release of 
Ring1B from these promoters. To achieve this, ES cell cultures were efficiently transfected 
with plasmids containing Suv39h1 under a CMV promoter. Although increased Suv39h1 
transcript levels were initially detected the expression this histone methyltransferase was 
not maintained and therefore no Suv39h1 expressing ES cell clones could be established, 
(F. Lavial, unpublished observation). This indicated that Suv39h1 over-expression is 
detrimental to ES cell survival and/or proliferation, consistent with previous attempts to 
over-express Suv39h1 using an in vivo transgenic approach, which gave rise to a low 
frequency of Suv39h1 over-expressing founder mice with mixed penetrance (Czvitkovich et 
al., 2001). However it may also be due to the use of a CMV promoter which is commonly 
silenced in ES cells. We were equally unsuccessful in addressing whether Suv39h1 
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depletion would conversely promote Ring1B binding at bivalent genes in TS cells, owing to 
the notorious difficulty of transfecting these cells in vitro. 
 An intriguing aspect of this study is the maintenance of high levels of H3K4me2/3 
at silent, lineage-inappropriate genes in TS cells and differentiated derivatives. Retention 
of bivalent chromatin domains was previously seen in other multipotent populations, 
including ES-derived neural precursor cells (NPC) (Mikkelsen et al., 2007). Mature T 
lymphocytes were also shown to harbor a large number (over 3000) of bivalent chromatin 
domains, many targets were not previously identified in ES cells (Roh et al., 2006). 
However, in contrast to TS cells, co-occupied loci in NPC and T cells mainly represented 
poised, lineage-appropriate genes that are ultimately induced upon, NPC differentiation or 
as part of an immune response in T cells (Mikkelsen et al., 2007; Roh et al., 2006).  
 Maintenance of a high level of methylated H3K4 across many genes in TS cells in 
consistent with an overall early replicating profile observed in this cell type, and other 
embryo-derived stem cells (i.e. ES and XEN cells) suggesting a common embryonic 
signature (J.Santos and O.Alder, unpublished observations). Indeed, the time at which a 
gene replicates during S phase is known to reflect its chromatin environment; early 
replication is associated with accessible chromatin while late replication tends to reflect 
more condensed conformations (Azuara et al., 2006; Gilbert, 2002; Perry et al., 2004). 
Interestingly early timing was recently shown to positively correlate with the presence of 
methylated H3K4, while repressive histone modifications show no strict relationship with 
this process (Hiratani et al., 2008).   
 Most importantly I observed the addition of H3K9me3 and DNA methylation can 
occur at key developmental genes without prior removal of H3K4 methylation in TS cells, 
an epigenetic state previously reported in embryonic carcinoma cells (Ohm et al., 2007). 
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This is in contrast to the prevailing view that loss of H3K4 methylation is a prerequisite for 
resolving poised chromatin at bivalent genes that are not activated upon differentiation 
(Bernstein et al., 2006a; Mikkelsen et al., 2007; Roh et al., 2006). This study, unexpectedly, 
reveals that additional layers of repressive epigenetic marks may provide an alternative 
strategy to resolve the poised status of key developmental loci during TE formation. While 
the presence of H3K4me2, H3K9me3 and H3K27me3 at the same loci was verified by 
sequential ChIP in TS cells it is unlikely that these occur on the same histone tail due to the 
inhibitory effects of H3K4 methylation on H3K9 methylation (Wang et al., 2001). Therefore 
it would be of interest to examine the distribution of each histone modification across 
different loci using a deep sequencing approach. One scenario would be that a discrete 
peak of H3K4 methylation is maintained near the TSS as previously seen at bivalent 
domains (Barski et al., 2007).  Whether H3K27me3 would also become more restricted and 
H3K9me3 occupies a more widespread domain, as suggested for H3K9me2 in 
differentiated somatic cells, remains to be established (Wen et al., 2009). 
 The addition of DNA methylation alongside H3K9me3 to lineage-inappropriate 
genes marked by H3K4me2/3 in TS cells was equally surprising in the light of previous 
data showing a mutual exclusion between these two marks. A crystallography study 
showed that de novo methylation by Dnmt3a2, a germ cell specific isoform of Dnmt3a, is 
abrogated by H3K4 methylation due to disrupted binding of the co-factor Dnmt3l (Ooi et 
al., 2007). One possible explanation that warrants further investigation is that the de novo 
methylation observed in TS cells at key developmental genes is mediated by Dnmt3b alone 
– a hypothesis supported by the expression patterns of these enzymes upon ES cells 
differentiation towards a TE cell fate. Interestingly comparative genome-wide DNA 
methylation analysis in ES cells and multipotent cells (NPC and Mefs) revealed that a 
discrete set of HCP loci associated with  the germline and embryonic development such as 
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Dazl are targeted by DNA methylation and carry bivalent chromatin domains, consistent 
with results shown in this study (Mikkelsen et al., 2007; Mohn et al., 2008)  
 
 To further explore whether trivalent chromatin domains may also occur in a 
lineage specific manner in vivo, I exploited a novel Carrier ChIP protocol that allows 
epigenetic analysis of cell samples taken directly from the developing embryo (O'Neill et 
al., 2006). Here I assessed the abundance of H3K4me2, H3K9me3 and H3K27me3 in 
morula stage embryos and isolated ICM and TE from the early blastosyst stage. A limited 
number of candidate loci were analysed including Sox1, Gata4 and Mixl1 that were shown 
to harbor differential histone marking (bivalent vs. trivalent) in ES and TS cells, 
respectively.  From this analysis I validated that distinct repressive pathways operate in 
the ICM and TE to silence key developmental genes due to the addition of H3K9me3 at 
genes with bivalent domains exclusively within in the TE. Most importantly H3K9me3 was 
not detected at silent loci in morulae suggesting that H3K9me3 acquisition occurs only as 
lineage segregation occurs. Whether Suv39h1 mediates the H3K9me3 observed in this 
study is not yet known, however, a role for Suv39h1 in pre-implantation development is 
supported by its progressive increase in expression (in contrast to Suv39h2) with a peak at 
the transition from morula to blastocyst (Puschendorf et al., 2008). In addition, higher 
levels of Suv39h1 were selectively detected, in contrast to any other H3K9 
methyltransferases analysed (e.g. ESET, Suv39h1 and G9a), in the TE compared to ICM or 
morula (F.Lavial and O.Alder, preliminary data). 
 The most intuitive interpretation of results presented in this study would be that 
Suv39h1 and DNA methylation act to consolidate TE cell fate acquisition by repressing key 
developmental genes and precluding reprogramming. This model is consistent with a 
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recent epigenetic study examining the ICM versus TE cell fate decision. In this case DNA 
methylation of trophoblast associated locus Elf5 was shown to consolidate ICM cell fate; ES 
cells deficient in DNA methylation were no longer restricted to an embryonic fate in 
chimera experiments (Ng et al., 2008). Our research group proposes to work in 
collaboration with Marie-Elena Torres Padilla to investigate whether modulating 
expression levels of Suv39h1 or other relevant candidates (i.e. Ring1B and Jmjd2c) in 
randomly selected blastomeres of a the 4-cell embryo may introduce a bias in cell fate 
allocation in subsequently cultured blastocyst embryos (Torres-Padilla et al., 2007). 
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Jmjd2c cttcacacagtttcggctca gatgactggccttacgtggt  
Appendix IA. Primers sequences used in this study for qPCR gene expression analysis 
Page | 118 
 



























      Utf1     ccctctccgcgttagcac cagacttcgtcgtggaagaac  
Appendix IA. (continued) Primers sequences used in this study for qPCR gene expression analysis  
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Locus Forward sequence Reverse sequence Primer distance from TSS (bp)
Actin ccccaacacacctagcaaat actgccccattcaatgtctc   301-591
Cdx2 accaccttctgcctgagaatgtac cctccaatcacaggttcaaagact    377-477
Fgfr2 gcaaagtttggagtaggcaacgc ggatcgcagaacagctaggacat    190-291
Flk1 gtggccaaagcaccataaaac agcatgaagacaagaacccct    414-515
Gata4      (C-ChIP) cccagctaaagctaaaggacaccaag ccaagtttccctccctcttc   203-388
Gata4 aagagcgcttgcgtctcta ttgatagcctcagatctacgg    147-418
Hand1 ggcctagcctacttccctgct cagcattcctgaacccgaact    380-455
Hoxa7 taacctgtccgcccaaagat gctggagcatcaaatcaggtct    376-477
Intergenic aaggggcctctgcttaaaa agagctccatggcaggtaga N/A
Math1 ccctcactcaggtcgcctg cgtgcgaggagccaatca    129-334
Mixl1       (C-ChIP) aggatgtgtcagggtggttt gctagaccttactccaggttgg   463-531
Mixl1 cacagatactctaggcaggagcagc cctgtcaccatcaaaggcgc    396-594
Oct4       (C-ChIP) ctgtaaggacaggccgagag caggaggccttcattttcaa    371-510
Pax3 gggcggatatagcaaggtttc cctgtccctctacatgagattcagc    265-366
Sox1        (C-ChIP) cctctttggcaagtggtttg aaaagaggcaaaagcacacg   181-268
Sox1 acaagaggaggcagcgaacc tcgcaggtggaaagtttctcc    221-433
Sox7 tccacagtgccagtttagggaa cagtaaacgtgggcagccac    482-578
-sats. aatcaaatgtgccgaggaa cagttgtttgtggcctcctt N/A
Tpbpa aagagacattagacttgaatatgctgactc aatggttctaggtaactttgagtggc    393-503
Pl1 ctgctggctggaaaatgagt tacctgaacccaaggagagc    108-328  
Appendix IB. Primers sequences used for qPCR analysis of ChIP and C-ChIP template and amplicon position relative to Transcriptional 
Start Site (TSS). 
 
 






Appendix II. Bivalent domains mark key embryonic regulators in extra-embryonic TS cells. 
Sequential ChIP firstly using anti-H3K4me2 and secondly anti-H3K27me3 antibodies were 
performed in ZHBTc4-ES and TS-B1 cells. Enrichment at selected promoters is expressed relative to 
H3. Data shown is from one experiment. Expression status is indicated below gene names, actively 
transcribed genes are marked (+).   
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Mean s.d. Mean s.d. Mean s.d. Mean s.d.
ESDox24 hrs ESDox24 hrs ESDox48 hrs ESDox48 hrs TSL TSL TS TS
Eed 0.37 0.04 0.27 0.16 0.03 0.04 0.08 0.02
Ezh2 0.73 0.07 0.75 0.41 0.44 0.17 0.67 0.01
Suz12 0.72 0.21 0.81 0.41 0.76 0.27 0.69 0.17
Bmi1 0.59 0.13 1.04 0.09 0.71 0.20 0.75 0.12
Cbx6 1.27 0.10 0.34 0.12 14.5 6.0 113.7 74.4
Cbx7 1.07 0.37 0.72 0.31 0.45 0.28 0.25 0.16
Cbx8 8.41 7.27 15.9 10.9 65.8 31.3 121.6 53.2
MBLR 0.19 0.00 0.11 0.01 0.07 0.01 0.48 0.41
Mel18 4.35 0.49 3.05 1.89 6.04 1.29 3.05 2.02
Phc1 0.97 0.16 0.81 0.08 0.55 0.20 0.21 0.14
Phc2 0.77 0.19 0.35 0.25 0.64 0.41 0.61 0.32
Ring1A 0.59 0.26 1.63 0.47 0.00 0.01 0.02 0.00
Ring1B 0.59 0.20 0.56 0.33 0.81 0.44 1.19 0.15
Mll1 0.65 0.19 0.71 0.28 0.81 0.14 1.02 0.11
Mll2 0.93 0.47 0.86 0.19 1.36 0.13 0.55 0.07
Mll3 0.66 0.29 0.72 0.18 0.16 0.16 0.11 0.04
Ehmt1 0.75 0.47 1.71 0.58 5.62 0.74 9.40 1.72
G9a 1.22 0.47 2.66 0.42 4.17 0.37 4.73 0.83
Suv39h1 2.36 0.22 5.96 0.56 31.8 2.88 29.5 5.09
Suv39h2 0.98 0.46 1.66 0.48 4.29 0.95 6.24 1.01
ESET 0.93 0.07 1.00 0.18 1.11 0.30 1.25 0.36
Jmjd3 6.73 0.40 3.18 0.86 2.19 0.35 6.40 2.75
Utx 0.83 0.25 1.07 0.47 0.49 0.50 0.72 0.52
LSD1 0.76 0.17 0.71 0.29 0.81 0.14 0.24 0.07
Jarid1a 0.86 0.25 1.28 0.78 1.02 0.72 1.57 0.50
Jarid1c 0.57 0.37 0.39 0.17 0.42 0.27 0.37 0.04
Jmjd1a 0.21 0.12 0.53 0.17 0.07 0.04 0.15 0.22
Jmjd2c 0.54 0.06 0.68 0.38 1.60 0.02 1.71 0.38
Jmjd2a 0.57 0.06 0.85 0.50 1.19 0.30 1.20 0.59
Jmjd2b 0.30 0.11 0.10 0.12 0.13 0.04 0.07 0.01
Dnmt1 1.01 0.74 0.87 0.38 0.68 0.56 1.36 0.63
Dnmt3a 1.17 0.47 0.54 0.41 0.04 0.14 0.04 0.04
Dnmt3b 1.45 0.34 1.58 0.76 0.50 0.39 1.31 0.28













Appendix III. Expression levels of selected chromatin modifying complexes upon Oct4 repression and TS-like cell derivation. 
The expression of selected chromatin modifying complexes was compared using qRT-PCR in; ZHBTc4-ES, ZHBTc4 after 24 and 48 
hours of Dox treatment (ESDox), in ZHBTc4-derived TSL and B1-TS cells (left panel),  . Values shown are normalised to Actin and L19 and 
are relative to untreated ES cells (ES=1, left panel). Data and corresponding s.d. results from 3 independent experiments.
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Appendix IV.  Targeted changes at key developmental genes upon Oct4 shutdown and TSL 
cell derivation. ChIP analysis of untreated  (ES) and Dox treated ZHBTc4 ES (ESDox) cells, ZHBTc4-
derived TS-like (TSL) cells and traditionally-derived TS-B1 (TS) cells at selected panel of loci.  
Relative enrichment of H3K27me3, H3K4me2 and H3K9me3 are shown relative to H3. Binding 
patterns of PRC2 (Suz12), PRC1 (Ring1B), Ser5P and hypophosphorylated RNAP II (8WG16) and 
Suv39h1 are shown relative to input. Background levels (from control IgG antibodies) are shown 
as grey bars. Data shown is representative of 3 experiments, error bars represent s.d. Brackets 
demarcate silent developmental genes that retain bivalent chromatin domains in TS cells. 





Appendix V. H3K4me2, H3K27me3 and H3K9me3 co-occupy key embryonic 
regulators in extra-embryonic TS cells. Sequential ChIP in TS cells using combinations of 
anti-H3K4me2, anti-H3K27me3 and H3K9me3 antibodies. Enrichment at selected 
promoters is expressed relative to H3. Data shown results from two experiments. Brackets 
indicate silent lineage-inappropriate genes that retain bivalent domains at their promoters 
in TS cells. (These experiments were carried out in collaboration with A. Helness) 




Appendix VI. Similar patterns of H3K4me2, H3K27me3 and H3K9me3 enrichment 
are detected in 8-cell and Morula stage embryos by C-ChIP analysis. Carrier ChIP and 
qPCR were used to assess levels of H3K4me2, H3K27me3 and H3K9me3 at the promoters 
of Oct4, Cdx2, Sox1, Gata4 and Mixl in 8-cell (light grey) and compacted morulae (dark grey) 
stage embryos. Antibody-bound and unbound chromatin fractions were amplified in 
parallel by qPCR using the same quantity of DNA. Enrichments are expressed as 
bound/unbound ratios. Error bars represent s.d. of 2 (8-cell) and 3 (morulae) independent 
experiments. * Note that a decrease of H3K27me3 is seen at Cdx2 in morula stage embryos 
compared to 8-cell stage embryos, consistent with its active transcriptional status.     
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